###begin article-title 0
###xml 17 22 <span type="species:ncbi:9606">Human</span>
###xml 57 65 <span type="species:ncbi:9606">Children</span>
Polymorphisms of Human Leukocyte Antigen Genes in Korean Children with Kawasaki Disease
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 65 73 <span type="species:ncbi:9606">children</span>
###xml 203 208 <span type="species:ncbi:9606">human</span>
###xml 444 452 <span type="species:ncbi:9606">children</span>
Kawasaki disease is a leading cause of acquired heart disease in children. The prevalence rate varies in different ethnic groups. Recently, with the clinical application of molecular genetic technology, human leukocyte antigen (HLA) polymorphisms associated with several diseases have been identified by DNA analysis. This study aimed to assess the association of HLA alleles with susceptibility and complications of Kawasaki disease in Korean children.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 41 49 <span type="species:ncbi:9606">children</span>
###xml 149 157 <span type="species:ncbi:9606">patients</span>
In this study, DNA was extracted from 74 children with a diagnosis of Kawasaki disease. The polymorphisms of the HLA-A, -B, -C, and -DRB1 alleles of patients with Kawasaki disease were determined by polymerase chain reaction (PCR)-amplification refractory mutation system (ARMS) and PCR-sequence-specific primer (SSP) analysis. The polymorphisms identified were compared with those of 159 normal healthy control subjects.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 95 103 <span type="species:ncbi:9606">patients</span>
###xml 253 261 <span type="species:ncbi:9606">patients</span>
###xml 310 318 <span type="species:ncbi:9606">patients</span>
###xml 435 443 <span type="species:ncbi:9606">patients</span>
There was a significant increase in the frequencies of the HLA-B35, -B75, and -Cw09 alleles in patients with Kawasaki disease compared with the healthy control group. There was no increase in the frequency of HLA-DRB1 alleles among the Kawasaki disease patients compared with a healthy control group. When the patients with Kawasaki disease were divided into two subgroups, with or without coronary complications, the Kawasaki disease patients with coronary complications showed a significantly increased frequency of the HLA-DRB1*11 allele compared with the healthy control group and increased frequency of HLA-DRB1*09 in a comparison of the subgroups.
###end p 6
###begin title 7
Conclusions
###end title 7
###begin p 8
###xml 134 142 <span type="species:ncbi:9606">children</span>
This study suggests that polymorphisms in some alleles of B and C in HLA class I genes are associated with Kawasaki disease in Korean children.
###end p 8
###begin title 9
Keywords
###end title 9
###begin p 10
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 105 113 <span type="species:ncbi:9606">children</span>
Kawasaki disease is a systemic vasculitis that currently is a leading cause of acquired heart disease in children. The etiology of Kawasaki disease continues to be unknown, although it was described 4 decades ago in 1967 by Kawasaki [15]. Diagnosis continues to depend primarily on clinical manifestations.
###end p 10
###begin p 11
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR4">4</xref>
###xml 638 640 638 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 388 396 <span type="species:ncbi:9606">children</span>
###xml 609 617 <span type="species:ncbi:9606">children</span>
It appears that the pathogenesis of Kawasaki disease is related to infection of a susceptible host coupled with epidemiologic and ethnic factors. In a study examining the epidemiologic characteristics of Kawasaki disease in San Diego, CA, USA, Asians/Pacific Islanders were 2.7 times more likely and Hispanics one-third as likely to be hospitalized for Kawasaki disease compared with the children of other ethnic groups combined [4]. The sibling risk ratio is also known to be higher, than the risk of being affected with Kawasaki disease without sibling history, and cases of Kawasaki disease in parents and children have been reported [10, 21].
###end p 11
###begin p 12
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 352 354 352 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 495 496 495 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 498 500 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 66 71 <span type="species:ncbi:9606">human</span>
For these reasons, many reports have suggested involvement of the human leukocyte antigen (HLA) system. The results of such studies vary depending on the ethnic group studied. Several reports show the association of HLA genotypes with Kawasaki disease including HLA-Bw22 (now referred to as HLA-B54) in Japanese [14, 20], HLA-B51 in white populations [13, 16, 18, 19], and the major histocompatibility complex class I chain-related gene A (MICA) genes and others in southern Chinese population [6, 12].
###end p 12
###begin p 13
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 109 110 109 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 239 247 <span type="species:ncbi:9606">patients</span>
###xml 376 384 <span type="species:ncbi:9606">children</span>
The major histocompatibility complex (MHC) class II genes in Kawasaki disease show variable correlations [2, 8, 27]. To date, there have been no reports supporting a consistent relationship between Kawasaki disease and HLA genes in Korean patients. Therefore, the current study aimed to assess the association of HLA-A,-B,-C, and -DRB1 alleles with Kawasaki disease in Korean children.
###end p 13
###begin title 14
Materials and Methods
###end title 14
###begin title 15
Subjects
###end title 15
###begin p 16
###xml 337 338 335 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 37 45 <span type="species:ncbi:9606">patients</span>
###xml 72 76 <span type="species:ncbi:9606">boys</span>
###xml 84 89 <span type="species:ncbi:9606">girls</span>
###xml 231 239 <span type="species:ncbi:9606">patients</span>
From March 2004 to December 2004, 74 patients with Kawasaki disease (44 boys and 30 girls) attending the pediatric outpatient clinic or admitted to St. Vincent's Hospital in Korea were recruited for this study. The mean age of the patients at diagnosis was 2.7 +/- 1.9 years. For comparison, genetically unrelated healthy Korean adults (n = 159) who had no history of Kawasaki disease were studied as a healthy control group. Blood samples were obtained after informed consent in compliance with the institutional review board of St. Vincent's hospital, College of Medicine, The Catholic University of Korea.
###end p 16
###begin p 17
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 715 716 715 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 718 725 718 725 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 725 767 725 767 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="18">Profiles of subjects with Kawasaki disease</p>
###xml 725 767 725 767 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="18">Profiles of subjects with Kawasaki disease</p></caption>
###xml 767 767 767 767 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"/>
###xml 767 768 767 768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 767 772 767 772 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left"><italic>n</italic> (%)</th>
###xml 767 772 767 772 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left"/><th align="left"><italic>n</italic> (%)</th></tr>
###xml 767 772 767 772 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left"/><th align="left"><italic>n</italic> (%)</th></tr></thead>
###xml 772 783 772 783 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Male/female</td>
###xml 783 796 783 796 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">44/30 (60/40)</td>
###xml 772 796 772 796 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Male/female</td><td char="(" align="char">44/30 (60/40)</td></tr>
###xml 796 818 796 818 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Typical KD/atypical KD</td>
###xml 818 830 818 830 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">65/9 (88/12)</td>
###xml 796 830 796 830 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Typical KD/atypical KD</td><td char="(" align="char">65/9 (88/12)</td></tr>
###xml 830 850 830 850 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Family history of KD</td>
###xml 850 857 850 857 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (4.1)</td>
###xml 830 857 830 857 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Family history of KD</td><td char="(" align="char">3 (4.1)</td></tr>
###xml 857 881 857 881 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Recurrence history of KD</td>
###xml 881 888 881 888 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">4 (5.4)</td>
###xml 857 888 857 888 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Recurrence history of KD</td><td char="(" align="char">4 (5.4)</td></tr>
###xml 888 910 888 910 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Coronary complications</td>
###xml 910 917 910 917 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">21 (28)</td>
###xml 888 917 888 917 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Coronary complications</td><td char="(" align="char">21 (28)</td></tr>
###xml 917 942 917 942 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">Other complications of KD</td>
###xml 917 942 917 942 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="2">Other complications of KD</td></tr>
###xml 942 961 942 961 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Gallbladder hydrops</td>
###xml 961 968 961 968 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">14 (19)</td>
###xml 942 968 942 968 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Gallbladder hydrops</td><td char="(" align="char">14 (19)</td></tr>
###xml 968 974 968 974 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Pyuria</td>
###xml 974 981 974 981 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">25 (34)</td>
###xml 968 981 968 981 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Pyuria</td><td char="(" align="char">25 (34)</td></tr>
###xml 981 992 981 992 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Hepatopathy</td>
###xml 992 999 992 999 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">38 (51)</td>
###xml 981 999 981 999 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Hepatopathy</td><td char="(" align="char">38 (51)</td></tr>
###xml 999 1008 999 1008 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Arthritis</td>
###xml 1008 1015 1008 1015 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">10 (14)</td>
###xml 999 1015 999 1015 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">Arthritis</td><td char="(" align="char">10 (14)</td></tr>
###xml 772 1015 772 1015 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left">Male/female</td><td char="(" align="char">44/30 (60/40)</td></tr><tr><td align="left">Typical KD/atypical KD</td><td char="(" align="char">65/9 (88/12)</td></tr><tr><td align="left">Family history of KD</td><td char="(" align="char">3 (4.1)</td></tr><tr><td align="left">Recurrence history of KD</td><td char="(" align="char">4 (5.4)</td></tr><tr><td align="left">Coronary complications</td><td char="(" align="char">21 (28)</td></tr><tr><td align="left" colspan="2">Other complications of KD</td></tr><tr><td align="left">Gallbladder hydrops</td><td char="(" align="char">14 (19)</td></tr><tr><td align="left">Pyuria</td><td char="(" align="char">25 (34)</td></tr><tr><td align="left">Hepatopathy</td><td char="(" align="char">38 (51)</td></tr><tr><td align="left">Arthritis</td><td char="(" align="char">10 (14)</td></tr></tbody>
###xml 767 1015 767 1015 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left"><italic>n</italic> (%)</th></tr></thead><tbody><tr><td align="left">Male/female</td><td char="(" align="char">44/30 (60/40)</td></tr><tr><td align="left">Typical KD/atypical KD</td><td char="(" align="char">65/9 (88/12)</td></tr><tr><td align="left">Family history of KD</td><td char="(" align="char">3 (4.1)</td></tr><tr><td align="left">Recurrence history of KD</td><td char="(" align="char">4 (5.4)</td></tr><tr><td align="left">Coronary complications</td><td char="(" align="char">21 (28)</td></tr><tr><td align="left" colspan="2">Other complications of KD</td></tr><tr><td align="left">Gallbladder hydrops</td><td char="(" align="char">14 (19)</td></tr><tr><td align="left">Pyuria</td><td char="(" align="char">25 (34)</td></tr><tr><td align="left">Hepatopathy</td><td char="(" align="char">38 (51)</td></tr><tr><td align="left">Arthritis</td><td char="(" align="char">10 (14)</td></tr></tbody></table>
###xml 1015 1035 1015 1035 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="19">KD, Kawasaki disease</p>
###xml 1015 1035 1015 1035 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="19">KD, Kawasaki disease</p></table-wrap-foot>
###xml 718 1035 718 1035 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="18">Profiles of subjects with Kawasaki disease</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left"><italic>n</italic> (%)</th></tr></thead><tbody><tr><td align="left">Male/female</td><td char="(" align="char">44/30 (60/40)</td></tr><tr><td align="left">Typical KD/atypical KD</td><td char="(" align="char">65/9 (88/12)</td></tr><tr><td align="left">Family history of KD</td><td char="(" align="char">3 (4.1)</td></tr><tr><td align="left">Recurrence history of KD</td><td char="(" align="char">4 (5.4)</td></tr><tr><td align="left">Coronary complications</td><td char="(" align="char">21 (28)</td></tr><tr><td align="left" colspan="2">Other complications of KD</td></tr><tr><td align="left">Gallbladder hydrops</td><td char="(" align="char">14 (19)</td></tr><tr><td align="left">Pyuria</td><td char="(" align="char">25 (34)</td></tr><tr><td align="left">Hepatopathy</td><td char="(" align="char">38 (51)</td></tr><tr><td align="left">Arthritis</td><td char="(" align="char">10 (14)</td></tr></tbody></table><table-wrap-foot><p textid="19">KD, Kawasaki disease</p></table-wrap-foot></table-wrap>
###xml 409 417 <span type="species:ncbi:9606">patients</span>
###xml 461 469 <span type="species:ncbi:9606">patients</span>
###xml 687 695 <span type="species:ncbi:9606">patients</span>
The diagnosis of Kawasaki disease was established by clinical manifestations meeting the defined criteria according to the report of the Research Committee on Kawasaki Disease of the Japanese Ministry of Health and Welfare in addition to exclusion of any other possible illnesses [25]. Coronary complications included the following lesions detected by echocardiography: an internal diameter exceeding 3 mm in patients younger than 5 years and exceeding 4 mm in patients age 5 years or older, dilation of a segmental luminal diameter to at least 1.5 times that of an adjacent segment, or a definitely irregular internal lumen of the coronary arteries. The clinical characteristics of the patients are shown in Table 1. Table 1Profiles of subjects with Kawasaki diseasen (%)Male/female44/30 (60/40)Typical KD/atypical KD65/9 (88/12)Family history of KD3 (4.1)Recurrence history of KD4 (5.4)Coronary complications21 (28)Other complications of KDGallbladder hydrops14 (19)Pyuria25 (34)Hepatopathy38 (51)Arthritis10 (14)KD, Kawasaki disease
###end p 17
###begin p 18
Profiles of subjects with Kawasaki disease
###end p 18
###begin p 19
KD, Kawasaki disease
###end p 19
###begin p 20
Genomic DNA was extracted by standard methods using the AccuPrep DNA extraction kit (Bioneer, Daejeon, Korea) from peripheral blood collected (4 ml) with ethylenediaminetetraacetic acid (EDTA) and kept at -20degreesC.
###end p 20
###begin title 21
HLA-A, -B, and -C Genotyping
###end title 21
###begin p 22
###xml 515 516 515 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR5">5</xref>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 522 524 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
The genotyping of HLA-A, -B, and -C was performed by the amplification refractory mutation system (ARMS)-polymerase chain reaction (PCR) method. Each reaction contained a primer mix consisting of the allele- or group-specific primer pairs as well as internal control primers matching nonallelic sequences. Specific amplifications of the HLA-A, -B, and -C genes were performed using forward and reverse primers (44 for HLA-A, 47 for HLA-B, and 33 for HLA-C) designed according to the published nucleotide sequences [5, 17, 26].
###end p 22
###begin p 23
###xml 140 141 139 140 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
The PCR procedure was carried out in a reaction (13 mul), containing 100 to 200 ng genomic DNA, 0.8 X buffer (40 mmol/l KCl, 1.2 mmol/l MgCl2, 8 mmol/l Tris-HCl pH 8.8, 0.08% Triton X-100), 5% dimethylsulphoxide (DMSO), 200 mumol/l of each dNTP, 0.25 U Taq DNA polymerase (Boehringer, Mannheim, Germany), 1 mumol/l of each sequence-specific primer, and 0.2 mumol/l of internal control primers.
###end p 23
###begin p 24
The amplifications were performed in a My Cycler thermocycler (Bio-Rad, Hercules, USA). For amplification, 30 cycles were performed using the following steps: heating to 96degreesC for 1 min to denature the DNA; denaturation at 96degreesC for 25 s and at 70degreesC for 45 s; annealing and extension at 72degreesC for 30 s (for the first 5 cycles), 96degreesC for 25 s, 65degreesC 45 s, 72degreesC for 30 s (for the next 21 cycles); 96degreesC for 25 s, 55degreesC for 60 s, 72degreesC for 120 s (for the last 4 cycles); and a final 1 min extension at 72degreesC. The presence or absence of PCR products was determined after separation of the samples on a 1.5% agarose gel containing 0.5 mug/ml of ethidium bromide.
###end p 24
###begin title 25
HLA-DRB1 Genotyping
###end title 25
###begin p 26
###xml 422 424 422 424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
The PCR sequence-specific primer (SSP) method was used for HLA-DRB1 genotyping. Each reaction contained a primer mix consisting of the allele- or group-specific primer pairs as well as the internal control primers that matched the nonallelic sequences. Specific amplification of the HLA-DRB1 gene was performed using 47 forward and reverse primers for HLA-DRB1 designed on the basis of the published nucleotide sequences [23].
###end p 26
###begin p 27
###xml 171 172 170 171 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
The PCR procedure was carried out in a reaction (10 mul) containing 100 ng genomic DNA, 1 X buffer (60 mmol/l Tris-HCl pH 9.0, 15 mmol/l ammonium sulphate, 2.5 mmol/l MgCl2), 200 mumol/l of each dNTP, 0.25 U Taq DNA polymerase (Boehringer Mannheim, Germany), 1 mumol/l of each sequence-specific primer, and 0.2 mumol/l of the internal control primers.
###end p 27
###begin p 28
The amplifications performed in a My Cycler thermocycler (Bio-Rad, Hercules, USA). For amplification, 27 cycles were performed using the following steps: heating to 96degreesC for 3 min to denature the DNA; denaturation at 96degreesC for 20 s; annealing and extension at 66degreesC for 60 s (for the first 10 cycles), 62degreesC for 80 s (for the next 10 cycles), and 61degreesC for 120 s (for the last 7 cycles); and a final 10 min extension at 72degreesC. The presence or absence of PCR products was determined after separation of samples on a 1.5% agarose gel containing 0.5 mug/ml of ethidium bromide.
###end p 28
###begin title 29
Statistical Analysis
###end title 29
###begin p 30
###xml 450 451 450 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 49 57 <span type="species:ncbi:9606">patients</span>
###xml 129 137 <span type="species:ncbi:9606">patients</span>
Statistical differences between Kawasaki disease patients and healthy control subjects and between subgroups of Kawasaki disease patients were tested with chi-square and Fisher's exact test. The quantification of the relationship of the frequencies studied, in cases with Kawasaki disease, was performed by calculating the relative risks using the method of Woolf. Haldane's modification was applied for cases in which the variables included zero. A p value less than 0.05 was considered to be significant.
###end p 30
###begin p 31
In this study, the data were not adjusted for multiple comparisons because the sample size was not large enough for multiple-comparison analysis correction.
###end p 31
###begin title 32
Results
###end title 32
###begin title 33
###xml 66 74 <span type="species:ncbi:9606">Patients</span>
The Genotype Distribution and Allele Frequencies of HLA-A for the Patients With Kawasaki Disease and the Healthy Control Group
###end title 33
###begin p 34
###xml 365 366 365 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 506 507 506 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 510 517 510 517 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 517 639 517 639 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="35">The allele frequencies of human leukocyte antigen-A (HLA-A) in the patients with Kawasaki disease and the control subjects</p>
###xml 517 639 517 639 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="35">The allele frequencies of human leukocyte antigen-A (HLA-A) in the patients with Kawasaki disease and the control subjects</p></caption>
###xml 639 650 639 650 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">HLA alleles</th>
###xml 668 669 668 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 676 677 676 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 650 681 650 681 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">Healthy controls (<italic>n</italic> =159) <italic>n</italic> (%)</th>
###xml 694 695 694 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 702 703 702 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 681 707 681 707 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">KD patients (<italic>n</italic> = 74) <italic>n</italic> (%)</th>
###xml 707 729 707 729 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">Coronary complications</th>
###xml 639 729 639 729 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="2">HLA alleles</th><th align="left" rowspan="2">Healthy controls (<italic>n</italic> =159) <italic>n</italic> (%)</th><th align="left" rowspan="2">KD patients (<italic>n</italic> = 74) <italic>n</italic> (%)</th><th align="left" colspan="2">Coronary complications</th></tr>
###xml 738 739 738 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 746 747 746 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 729 751 729 751 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Present (<italic>n</italic> = 21) <italic>n</italic> (%)</th>
###xml 759 760 759 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 766 767 766 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 751 771 751 771 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Absent (<italic>n</italic> = 53 <italic>n</italic> (%)</th>
###xml 729 771 729 771 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Present (<italic>n</italic> = 21) <italic>n</italic> (%)</th><th align="left">Absent (<italic>n</italic> = 53 <italic>n</italic> (%)</th></tr>
###xml 639 771 639 771 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="2">HLA alleles</th><th align="left" rowspan="2">Healthy controls (<italic>n</italic> =159) <italic>n</italic> (%)</th><th align="left" rowspan="2">KD patients (<italic>n</italic> = 74) <italic>n</italic> (%)</th><th align="left" colspan="2">Coronary complications</th></tr><tr><th align="left">Present (<italic>n</italic> = 21) <italic>n</italic> (%)</th><th align="left">Absent (<italic>n</italic> = 53 <italic>n</italic> (%)</th></tr></thead>
###xml 771 776 771 776 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="5">HLA-A</td>
###xml 771 776 771 776 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="5">HLA-A</td></tr>
###xml 776 778 776 778 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">01</td>
###xml 778 785 778 785 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5 (3.1)</td>
###xml 785 792 785 792 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5 (6.8)</td>
###xml 792 799 792 799 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2 (9.5)</td>
###xml 799 806 799 806 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3 (5.7)</td>
###xml 776 806 776 806 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">01</td><td align="left">5 (3.1)</td><td align="left">5 (6.8)</td><td align="left">2 (9.5)</td><td align="left">3 (5.7)</td></tr>
###xml 806 808 806 808 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">02</td>
###xml 808 817 808 817 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">85 (53.5)</td>
###xml 817 826 817 826 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">43 (58.1)</td>
###xml 826 835 826 835 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">12 (57.1)</td>
###xml 835 844 835 844 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">31 (58.5)</td>
###xml 806 844 806 844 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">02</td><td align="left">85 (53.5)</td><td align="left">43 (58.1)</td><td align="left">12 (57.1)</td><td align="left">31 (58.5)</td></tr>
###xml 844 846 844 846 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">03</td>
###xml 846 853 846 853 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">5 (3.1)</td>
###xml 853 860 853 860 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3 (4.1)</td>
###xml 860 867 860 867 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0 (0.0)</td>
###xml 867 874 867 874 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3 (5.7)</td>
###xml 844 874 844 874 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">03</td><td align="left">5 (3.1)</td><td align="left">3 (4.1)</td><td align="left">0 (0.0)</td><td align="left">3 (5.7)</td></tr>
###xml 874 876 874 876 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">11</td>
###xml 876 885 876 885 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">31 (19.5)</td>
###xml 885 894 885 894 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">21 (28.4)</td>
###xml 894 902 894 902 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">6 (28.6)</td>
###xml 902 911 902 911 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">15 (28.3)</td>
###xml 874 911 874 911 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">11</td><td align="left">31 (19.5)</td><td align="left">21 (28.4)</td><td align="left">6 (28.6)</td><td align="left">15 (28.3)</td></tr>
###xml 911 913 911 913 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">24</td>
###xml 913 922 913 922 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">57 (35.8)</td>
###xml 922 931 922 931 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">33 (44.6)</td>
###xml 931 940 931 940 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">12 (57.1)</td>
###xml 940 949 940 949 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">21 (39.6)</td>
###xml 911 949 911 949 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">24</td><td align="left">57 (35.8)</td><td align="left">33 (44.6)</td><td align="left">12 (57.1)</td><td align="left">21 (39.6)</td></tr>
###xml 949 951 949 951 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">26</td>
###xml 951 960 951 960 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">25 (15.7)</td>
###xml 960 967 960 967 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">6 (8.1)</td>
###xml 967 975 967 975 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">4 (19.0)</td>
###xml 982 983 982 983 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 975 983 975 983 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2 (3.8)<sup>a</sup></td>
###xml 949 983 949 983 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">26</td><td align="left">25 (15.7)</td><td align="left">6 (8.1)</td><td align="left">4 (19.0)</td><td align="left">2 (3.8)<sup>a</sup></td></tr>
###xml 983 985 983 985 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">30</td>
###xml 985 994 985 994 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">20 (12.6)</td>
###xml 994 1001 994 1001 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">4 (5.4)</td>
###xml 1001 1008 1001 1008 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1 (4.8)</td>
###xml 1008 1015 1008 1015 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3 (5.7)</td>
###xml 983 1015 983 1015 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">30</td><td align="left">20 (12.6)</td><td align="left">4 (5.4)</td><td align="left">1 (4.8)</td><td align="left">3 (5.7)</td></tr>
###xml 1015 1017 1015 1017 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">31</td>
###xml 1017 1025 1017 1025 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">14 (8.8)</td>
###xml 1025 1032 1025 1032 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">6 (8.1)</td>
###xml 1032 1039 1032 1039 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0 (0.0)</td>
###xml 1039 1047 1039 1047 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">6 (11.3)</td>
###xml 1015 1047 1015 1047 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">31</td><td align="left">14 (8.8)</td><td align="left">6 (8.1)</td><td align="left">0 (0.0)</td><td align="left">6 (11.3)</td></tr>
###xml 1047 1049 1047 1049 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">32</td>
###xml 1049 1056 1049 1056 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">3 (1.9)</td>
###xml 1056 1063 1056 1063 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0 (0.0)</td>
###xml 1063 1070 1063 1070 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0 (0.0)</td>
###xml 1070 1077 1070 1077 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0 (0.0)</td>
###xml 1047 1077 1047 1077 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">32</td><td align="left">3 (1.9)</td><td align="left">0 (0.0)</td><td align="left">0 (0.0)</td><td align="left">0 (0.0)</td></tr>
###xml 1077 1079 1077 1079 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">33</td>
###xml 1079 1088 1079 1088 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">38 (23.9)</td>
###xml 1088 1097 1088 1097 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">15 (20.3)</td>
###xml 1097 1104 1097 1104 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">2 (9.5)</td>
###xml 1104 1113 1104 1113 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">13 (24.5)</td>
###xml 1077 1113 1077 1113 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">33</td><td align="left">38 (23.9)</td><td align="left">15 (20.3)</td><td align="left">2 (9.5)</td><td align="left">13 (24.5)</td></tr>
###xml 1113 1115 1113 1115 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">68</td>
###xml 1115 1122 1115 1122 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">1 (0.6)</td>
###xml 1122 1129 1122 1129 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0 (0.0)</td>
###xml 1129 1136 1129 1136 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0 (0.0)</td>
###xml 1136 1143 1136 1143 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">0 (0.0)</td>
###xml 1113 1143 1113 1143 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">68</td><td align="left">1 (0.6)</td><td align="left">0 (0.0)</td><td align="left">0 (0.0)</td><td align="left">0 (0.0)</td></tr>
###xml 771 1143 771 1143 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left" colspan="5">HLA-A</td></tr><tr><td align="left">01</td><td align="left">5 (3.1)</td><td align="left">5 (6.8)</td><td align="left">2 (9.5)</td><td align="left">3 (5.7)</td></tr><tr><td align="left">02</td><td align="left">85 (53.5)</td><td align="left">43 (58.1)</td><td align="left">12 (57.1)</td><td align="left">31 (58.5)</td></tr><tr><td align="left">03</td><td align="left">5 (3.1)</td><td align="left">3 (4.1)</td><td align="left">0 (0.0)</td><td align="left">3 (5.7)</td></tr><tr><td align="left">11</td><td align="left">31 (19.5)</td><td align="left">21 (28.4)</td><td align="left">6 (28.6)</td><td align="left">15 (28.3)</td></tr><tr><td align="left">24</td><td align="left">57 (35.8)</td><td align="left">33 (44.6)</td><td align="left">12 (57.1)</td><td align="left">21 (39.6)</td></tr><tr><td align="left">26</td><td align="left">25 (15.7)</td><td align="left">6 (8.1)</td><td align="left">4 (19.0)</td><td align="left">2 (3.8)<sup>a</sup></td></tr><tr><td align="left">30</td><td align="left">20 (12.6)</td><td align="left">4 (5.4)</td><td align="left">1 (4.8)</td><td align="left">3 (5.7)</td></tr><tr><td align="left">31</td><td align="left">14 (8.8)</td><td align="left">6 (8.1)</td><td align="left">0 (0.0)</td><td align="left">6 (11.3)</td></tr><tr><td align="left">32</td><td align="left">3 (1.9)</td><td align="left">0 (0.0)</td><td align="left">0 (0.0)</td><td align="left">0 (0.0)</td></tr><tr><td align="left">33</td><td align="left">38 (23.9)</td><td align="left">15 (20.3)</td><td align="left">2 (9.5)</td><td align="left">13 (24.5)</td></tr><tr><td align="left">68</td><td align="left">1 (0.6)</td><td align="left">0 (0.0)</td><td align="left">0 (0.0)</td><td align="left">0 (0.0)</td></tr></tbody>
###xml 639 1143 639 1143 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">HLA alleles</th><th align="left" rowspan="2">Healthy controls (<italic>n</italic> =159) <italic>n</italic> (%)</th><th align="left" rowspan="2">KD patients (<italic>n</italic> = 74) <italic>n</italic> (%)</th><th align="left" colspan="2">Coronary complications</th></tr><tr><th align="left">Present (<italic>n</italic> = 21) <italic>n</italic> (%)</th><th align="left">Absent (<italic>n</italic> = 53 <italic>n</italic> (%)</th></tr></thead><tbody><tr><td align="left" colspan="5">HLA-A</td></tr><tr><td align="left">01</td><td align="left">5 (3.1)</td><td align="left">5 (6.8)</td><td align="left">2 (9.5)</td><td align="left">3 (5.7)</td></tr><tr><td align="left">02</td><td align="left">85 (53.5)</td><td align="left">43 (58.1)</td><td align="left">12 (57.1)</td><td align="left">31 (58.5)</td></tr><tr><td align="left">03</td><td align="left">5 (3.1)</td><td align="left">3 (4.1)</td><td align="left">0 (0.0)</td><td align="left">3 (5.7)</td></tr><tr><td align="left">11</td><td align="left">31 (19.5)</td><td align="left">21 (28.4)</td><td align="left">6 (28.6)</td><td align="left">15 (28.3)</td></tr><tr><td align="left">24</td><td align="left">57 (35.8)</td><td align="left">33 (44.6)</td><td align="left">12 (57.1)</td><td align="left">21 (39.6)</td></tr><tr><td align="left">26</td><td align="left">25 (15.7)</td><td align="left">6 (8.1)</td><td align="left">4 (19.0)</td><td align="left">2 (3.8)<sup>a</sup></td></tr><tr><td align="left">30</td><td align="left">20 (12.6)</td><td align="left">4 (5.4)</td><td align="left">1 (4.8)</td><td align="left">3 (5.7)</td></tr><tr><td align="left">31</td><td align="left">14 (8.8)</td><td align="left">6 (8.1)</td><td align="left">0 (0.0)</td><td align="left">6 (11.3)</td></tr><tr><td align="left">32</td><td align="left">3 (1.9)</td><td align="left">0 (0.0)</td><td align="left">0 (0.0)</td><td align="left">0 (0.0)</td></tr><tr><td align="left">33</td><td align="left">38 (23.9)</td><td align="left">15 (20.3)</td><td align="left">2 (9.5)</td><td align="left">13 (24.5)</td></tr><tr><td align="left">68</td><td align="left">1 (0.6)</td><td align="left">0 (0.0)</td><td align="left">0 (0.0)</td><td align="left">0 (0.0)</td></tr></tbody></table>
###xml 1143 1182 1143 1182 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="36">KD, Kawasaki disease; RR, relative risk</p>
###xml 1182 1183 1182 1183 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1183 1184 1183 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1182 1271 1182 1271 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="37"><sup>a</sup><italic>p</italic> &lt; 0.04; RR = 0.2 (95% confidence interval [CI], 0.05&#8211;0.90) vs healthy control subjects</p>
###xml 1143 1271 1143 1271 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="36">KD, Kawasaki disease; RR, relative risk</p><p textid="37"><sup>a</sup><italic>p</italic> &lt; 0.04; RR = 0.2 (95% confidence interval [CI], 0.05&#8211;0.90) vs healthy control subjects</p></table-wrap-foot>
###xml 510 1271 510 1271 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="35">The allele frequencies of human leukocyte antigen-A (HLA-A) in the patients with Kawasaki disease and the control subjects</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">HLA alleles</th><th align="left" rowspan="2">Healthy controls (<italic>n</italic> =159) <italic>n</italic> (%)</th><th align="left" rowspan="2">KD patients (<italic>n</italic> = 74) <italic>n</italic> (%)</th><th align="left" colspan="2">Coronary complications</th></tr><tr><th align="left">Present (<italic>n</italic> = 21) <italic>n</italic> (%)</th><th align="left">Absent (<italic>n</italic> = 53 <italic>n</italic> (%)</th></tr></thead><tbody><tr><td align="left" colspan="5">HLA-A</td></tr><tr><td align="left">01</td><td align="left">5 (3.1)</td><td align="left">5 (6.8)</td><td align="left">2 (9.5)</td><td align="left">3 (5.7)</td></tr><tr><td align="left">02</td><td align="left">85 (53.5)</td><td align="left">43 (58.1)</td><td align="left">12 (57.1)</td><td align="left">31 (58.5)</td></tr><tr><td align="left">03</td><td align="left">5 (3.1)</td><td align="left">3 (4.1)</td><td align="left">0 (0.0)</td><td align="left">3 (5.7)</td></tr><tr><td align="left">11</td><td align="left">31 (19.5)</td><td align="left">21 (28.4)</td><td align="left">6 (28.6)</td><td align="left">15 (28.3)</td></tr><tr><td align="left">24</td><td align="left">57 (35.8)</td><td align="left">33 (44.6)</td><td align="left">12 (57.1)</td><td align="left">21 (39.6)</td></tr><tr><td align="left">26</td><td align="left">25 (15.7)</td><td align="left">6 (8.1)</td><td align="left">4 (19.0)</td><td align="left">2 (3.8)<sup>a</sup></td></tr><tr><td align="left">30</td><td align="left">20 (12.6)</td><td align="left">4 (5.4)</td><td align="left">1 (4.8)</td><td align="left">3 (5.7)</td></tr><tr><td align="left">31</td><td align="left">14 (8.8)</td><td align="left">6 (8.1)</td><td align="left">0 (0.0)</td><td align="left">6 (11.3)</td></tr><tr><td align="left">32</td><td align="left">3 (1.9)</td><td align="left">0 (0.0)</td><td align="left">0 (0.0)</td><td align="left">0 (0.0)</td></tr><tr><td align="left">33</td><td align="left">38 (23.9)</td><td align="left">15 (20.3)</td><td align="left">2 (9.5)</td><td align="left">13 (24.5)</td></tr><tr><td align="left">68</td><td align="left">1 (0.6)</td><td align="left">0 (0.0)</td><td align="left">0 (0.0)</td><td align="left">0 (0.0)</td></tr></tbody></table><table-wrap-foot><p textid="36">KD, Kawasaki disease; RR, relative risk</p><p textid="37"><sup>a</sup><italic>p</italic> &lt; 0.04; RR = 0.2 (95% confidence interval [CI], 0.05&#8211;0.90) vs healthy control subjects</p></table-wrap-foot></table-wrap>
###xml 131 139 <span type="species:ncbi:9606">patients</span>
###xml 279 287 <span type="species:ncbi:9606">patients</span>
###xml 543 548 <span type="species:ncbi:9606">human</span>
###xml 584 592 <span type="species:ncbi:9606">patients</span>
###xml 684 692 <span type="species:ncbi:9606">patients</span>
In the analysis of the polymorphisms of HLA-A alleles, no statistical difference was found in the frequency of alleles between the patients with Kawasaki disease and the control group. However, the frequency of HLA-A26 alleles was significantly decreased in the Kawasaki disease patients without coronary complications (CC) compared with the healthy control group (p < 0.04; relative risk (RR) = 0.2). In a comparison between subgroups, with and without CC, no significant difference was identified (Table 2). Table 2The allele frequencies of human leukocyte antigen-A (HLA-A) in the patients with Kawasaki disease and the control subjectsHLA allelesHealthy controls (n =159) n (%)KD patients (n = 74) n (%)Coronary complicationsPresent (n = 21) n (%)Absent (n = 53 n (%)HLA-A015 (3.1)5 (6.8)2 (9.5)3 (5.7)0285 (53.5)43 (58.1)12 (57.1)31 (58.5)035 (3.1)3 (4.1)0 (0.0)3 (5.7)1131 (19.5)21 (28.4)6 (28.6)15 (28.3)2457 (35.8)33 (44.6)12 (57.1)21 (39.6)2625 (15.7)6 (8.1)4 (19.0)2 (3.8)a3020 (12.6)4 (5.4)1 (4.8)3 (5.7)3114 (8.8)6 (8.1)0 (0.0)6 (11.3)323 (1.9)0 (0.0)0 (0.0)0 (0.0)3338 (23.9)15 (20.3)2 (9.5)13 (24.5)681 (0.6)0 (0.0)0 (0.0)0 (0.0)KD, Kawasaki disease; RR, relative riskap < 0.04; RR = 0.2 (95% confidence interval [CI], 0.05-0.90) vs healthy control subjects
###end p 34
###begin p 35
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 67 75 <span type="species:ncbi:9606">patients</span>
The allele frequencies of human leukocyte antigen-A (HLA-A) in the patients with Kawasaki disease and the control subjects
###end p 35
###begin p 36
KD, Kawasaki disease; RR, relative risk
###end p 36
###begin p 37
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
ap < 0.04; RR = 0.2 (95% confidence interval [CI], 0.05-0.90) vs healthy control subjects
###end p 37
###begin title 38
###xml 66 74 <span type="species:ncbi:9606">Patients</span>
The Genotype Distribution and Allele Frequencies of HLA-B for the Patients With Kawasaki Disease and the Healthy Control Group
###end title 38
###begin p 39
###xml 200 201 200 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 223 224 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 490 491 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 512 513 512 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 539 540 539 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab3" ref-type="table">3</xref>
###xml 1043 1050 1043 1050 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;3</label>
###xml 1050 1172 1050 1172 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="40">The allele frequencies of human leukocyte antigen-B (HLA-B) in the patients with Kawasaki disease and the control subjects</p>
###xml 1050 1172 1050 1172 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="40">The allele frequencies of human leukocyte antigen-B (HLA-B) in the patients with Kawasaki disease and the control subjects</p></caption>
###xml 1172 1183 1172 1183 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">HLA alleles</th>
###xml 1201 1202 1201 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1210 1211 1210 1211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1183 1215 1183 1215 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">Healthy controls (<italic>n</italic> = 159) <italic>n</italic> (%)</th>
###xml 1228 1229 1228 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1236 1237 1236 1237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1215 1241 1215 1241 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">KD patients (<italic>n</italic> = 74) <italic>n</italic> (%)</th>
###xml 1241 1263 1241 1263 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">Coronary complications</th>
###xml 1172 1263 1172 1263 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="2">HLA alleles</th><th align="left" rowspan="2">Healthy controls (<italic>n</italic> = 159) <italic>n</italic> (%)</th><th align="left" rowspan="2">KD patients (<italic>n</italic> = 74) <italic>n</italic> (%)</th><th align="left" colspan="2">Coronary complications</th></tr>
###xml 1272 1273 1272 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1280 1281 1280 1281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1263 1285 1263 1285 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Present (<italic>n</italic> = 21) <italic>n</italic> (%)</th>
###xml 1293 1294 1293 1294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1301 1302 1301 1302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1285 1306 1285 1306 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Absent (<italic>n</italic> = 53) <italic>n</italic> (%)</th>
###xml 1263 1306 1263 1306 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Present (<italic>n</italic> = 21) <italic>n</italic> (%)</th><th align="left">Absent (<italic>n</italic> = 53) <italic>n</italic> (%)</th></tr>
###xml 1172 1306 1172 1306 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="2">HLA alleles</th><th align="left" rowspan="2">Healthy controls (<italic>n</italic> = 159) <italic>n</italic> (%)</th><th align="left" rowspan="2">KD patients (<italic>n</italic> = 74) <italic>n</italic> (%)</th><th align="left" colspan="2">Coronary complications</th></tr><tr><th align="left">Present (<italic>n</italic> = 21) <italic>n</italic> (%)</th><th align="left">Absent (<italic>n</italic> = 53) <italic>n</italic> (%)</th></tr></thead>
###xml 1306 1311 1306 1311 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="5">HLA-B</td>
###xml 1306 1311 1306 1311 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="5">HLA-B</td></tr>
###xml 1311 1313 1311 1313 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">07</td>
###xml 1313 1322 1313 1322 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">19 (11.9)</td>
###xml 1322 1330 1322 1330 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">9 (12.2)</td>
###xml 1330 1338 1330 1338 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (14.3)</td>
###xml 1338 1346 1338 1346 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">6 (11.3)</td>
###xml 1311 1346 1311 1346 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">07</td><td char="(" align="char">19 (11.9)</td><td char="(" align="char">9 (12.2)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">6 (11.3)</td></tr>
###xml 1346 1348 1346 1348 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">08</td>
###xml 1348 1355 1348 1355 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (1.3)</td>
###xml 1355 1362 1355 1362 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 1362 1369 1362 1369 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 1369 1376 1369 1376 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 1346 1376 1346 1376 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">08</td><td char="(" align="char">2 (1.3)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td></tr>
###xml 1376 1378 1376 1378 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">13</td>
###xml 1378 1387 1378 1387 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">20 (12.6)</td>
###xml 1387 1394 1387 1394 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5 (6.8)</td>
###xml 1394 1401 1394 1401 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (9.5)</td>
###xml 1401 1408 1401 1408 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (5.7)</td>
###xml 1376 1408 1376 1408 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">13</td><td char="(" align="char">20 (12.6)</td><td char="(" align="char">5 (6.8)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">3 (5.7)</td></tr>
###xml 1408 1410 1408 1410 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">14</td>
###xml 1410 1417 1410 1417 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">6 (3.8)</td>
###xml 1417 1424 1417 1424 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 1424 1431 1424 1431 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 1431 1438 1431 1438 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 1408 1438 1408 1438 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">14</td><td char="(" align="char">6 (3.8)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td></tr>
###xml 1438 1440 1438 1440 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">27</td>
###xml 1440 1448 1440 1448 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">11 (6.9)</td>
###xml 1448 1455 1448 1455 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (4.1)</td>
###xml 1455 1462 1455 1462 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (4.8)</td>
###xml 1462 1469 1462 1469 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (3.8)</td>
###xml 1438 1469 1438 1469 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">27</td><td char="(" align="char">11 (6.9)</td><td char="(" align="char">3 (4.1)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">2 (3.8)</td></tr>
###xml 1469 1471 1469 1471 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">35</td>
###xml 1471 1479 1471 1479 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">11 (6.9)</td>
###xml 1488 1489 1488 1489 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1479 1489 1479 1489 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">14 (18.9)<sup>a</sup></td>
###xml 1489 1497 1489 1497 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">4 (19.0)</td>
###xml 1506 1507 1506 1507 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1497 1507 1497 1507 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">10 (18.9)<sup>b</sup></td>
###xml 1469 1507 1469 1507 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">35</td><td char="(" align="char">11 (6.9)</td><td char="(" align="char">14 (18.9)<sup>a</sup></td><td char="(" align="char">4 (19.0)</td><td char="(" align="char">10 (18.9)<sup>b</sup></td></tr>
###xml 1507 1509 1507 1509 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">37</td>
###xml 1509 1516 1509 1516 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5 (3.1)</td>
###xml 1516 1523 1516 1523 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">4 (5.4)</td>
###xml 1523 1530 1523 1530 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (9.5)</td>
###xml 1530 1537 1530 1537 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (3.8)</td>
###xml 1507 1537 1507 1537 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">37</td><td char="(" align="char">5 (3.1)</td><td char="(" align="char">4 (5.4)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">2 (3.8)</td></tr>
###xml 1537 1539 1537 1539 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">38</td>
###xml 1539 1546 1539 1546 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7 (4.4)</td>
###xml 1546 1553 1546 1553 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (4.1)</td>
###xml 1553 1560 1553 1560 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 1560 1567 1560 1567 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (5.7)</td>
###xml 1537 1567 1537 1567 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">38</td><td char="(" align="char">7 (4.4)</td><td char="(" align="char">3 (4.1)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">3 (5.7)</td></tr>
###xml 1567 1569 1567 1569 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">39</td>
###xml 1569 1576 1569 1576 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (1.3)</td>
###xml 1576 1583 1576 1583 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (4.1)</td>
###xml 1583 1590 1583 1590 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (9.5)</td>
###xml 1590 1597 1590 1597 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (1.9)</td>
###xml 1567 1597 1567 1597 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">39</td><td char="(" align="char">2 (1.3)</td><td char="(" align="char">3 (4.1)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">1 (1.9)</td></tr>
###xml 1597 1599 1597 1599 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">44</td>
###xml 1599 1608 1599 1608 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">29 (18.2)</td>
###xml 1608 1617 1608 1617 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">10 (13.5)</td>
###xml 1617 1625 1617 1625 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (14.3)</td>
###xml 1625 1633 1625 1633 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7 (13.2)</td>
###xml 1597 1633 1597 1633 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">44</td><td char="(" align="char">29 (18.2)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">7 (13.2)</td></tr>
###xml 1633 1635 1633 1635 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">46</td>
###xml 1635 1644 1635 1644 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">18 (11.3)</td>
###xml 1644 1651 1644 1651 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7 (9.5)</td>
###xml 1651 1658 1651 1658 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (9.5)</td>
###xml 1658 1665 1658 1665 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5 (9.4)</td>
###xml 1633 1665 1633 1665 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">46</td><td char="(" align="char">18 (11.3)</td><td char="(" align="char">7 (9.5)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">5 (9.4)</td></tr>
###xml 1665 1667 1665 1667 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">47</td>
###xml 1667 1674 1667 1674 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 1674 1681 1674 1681 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (1.4)</td>
###xml 1681 1688 1681 1688 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 1688 1695 1688 1695 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (1.9)</td>
###xml 1665 1695 1665 1695 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">47</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr>
###xml 1695 1697 1695 1697 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">48</td>
###xml 1697 1705 1697 1705 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">13 (8.2)</td>
###xml 1705 1712 1705 1712 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (2.7)</td>
###xml 1712 1719 1712 1719 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 1719 1726 1719 1726 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (3.8)</td>
###xml 1695 1726 1695 1726 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">48</td><td char="(" align="char">13 (8.2)</td><td char="(" align="char">2 (2.7)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">2 (3.8)</td></tr>
###xml 1726 1728 1726 1728 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">51</td>
###xml 1728 1737 1728 1737 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">29 (18.2)</td>
###xml 1737 1746 1737 1746 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">13 (17.6)</td>
###xml 1746 1754 1746 1754 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5 (23.8)</td>
###xml 1754 1762 1754 1762 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">8 (15.1)</td>
###xml 1726 1762 1726 1762 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">51</td><td char="(" align="char">29 (18.2)</td><td char="(" align="char">13 (17.6)</td><td char="(" align="char">5 (23.8)</td><td char="(" align="char">8 (15.1)</td></tr>
###xml 1762 1764 1762 1764 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">52</td>
###xml 1764 1771 1764 1771 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">9 (5.7)</td>
###xml 1771 1778 1771 1778 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (4.1)</td>
###xml 1778 1785 1778 1785 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (9.5)</td>
###xml 1785 1792 1785 1792 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (1.9)</td>
###xml 1762 1792 1762 1792 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">52</td><td char="(" align="char">9 (5.7)</td><td char="(" align="char">3 (4.1)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">1 (1.9)</td></tr>
###xml 1792 1794 1792 1794 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">54</td>
###xml 1794 1803 1794 1803 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">23 (14.5)</td>
###xml 1803 1812 1803 1812 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">10 (13.5)</td>
###xml 1812 1820 1812 1820 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (14.3)</td>
###xml 1820 1828 1820 1828 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7 (13.2)</td>
###xml 1792 1828 1792 1828 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">54</td><td char="(" align="char">23 (14.5)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">7 (13.2)</td></tr>
###xml 1828 1830 1828 1830 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">55</td>
###xml 1830 1837 1830 1837 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (1.9)</td>
###xml 1837 1844 1837 1844 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">4 (5.4)</td>
###xml 1844 1851 1844 1851 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (4.8)</td>
###xml 1851 1858 1851 1858 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (5.7)</td>
###xml 1828 1858 1828 1858 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">55</td><td char="(" align="char">3 (1.9)</td><td char="(" align="char">4 (5.4)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">3 (5.7)</td></tr>
###xml 1858 1860 1858 1860 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">56</td>
###xml 1860 1867 1860 1867 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (1.3)</td>
###xml 1867 1874 1867 1874 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 1874 1881 1874 1881 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 1881 1888 1881 1888 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 1858 1888 1858 1888 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">56</td><td char="(" align="char">2 (1.3)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td></tr>
###xml 1888 1890 1888 1890 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">57</td>
###xml 1890 1897 1890 1897 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (1.3)</td>
###xml 1897 1904 1897 1904 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (1.4)</td>
###xml 1904 1911 1904 1911 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 1911 1918 1911 1918 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (1.9)</td>
###xml 1888 1918 1888 1918 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">57</td><td char="(" align="char">2 (1.3)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr>
###xml 1918 1920 1918 1920 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">58</td>
###xml 1920 1928 1920 1928 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">15 (9.4)</td>
###xml 1928 1935 1928 1935 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5 (6.8)</td>
###xml 1935 1942 1935 1942 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 1942 1949 1942 1949 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5 (9.4)</td>
###xml 1918 1949 1918 1949 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">58</td><td char="(" align="char">15 (9.4)</td><td char="(" align="char">5 (6.8)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">5 (9.4)</td></tr>
###xml 1949 1951 1949 1951 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">59</td>
###xml 1951 1958 1951 1958 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">4 (2.5)</td>
###xml 1958 1965 1958 1965 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (4.1)</td>
###xml 1965 1972 1965 1972 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 1972 1979 1972 1979 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (5.7)</td>
###xml 1949 1979 1949 1979 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">59</td><td char="(" align="char">4 (2.5)</td><td char="(" align="char">3 (4.1)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">3 (5.7)</td></tr>
###xml 1979 1981 1979 1981 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">60</td>
###xml 1981 1989 1981 1989 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">11 (6.9)</td>
###xml 1989 1996 1989 1996 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7 (9.5)</td>
###xml 1996 2003 1996 2003 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (9.5)</td>
###xml 2003 2010 2003 2010 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5 (9.4)</td>
###xml 1979 2010 1979 2010 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">60</td><td char="(" align="char">11 (6.9)</td><td char="(" align="char">7 (9.5)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">5 (9.4)</td></tr>
###xml 2010 2012 2010 2012 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">61</td>
###xml 2012 2021 2012 2021 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">23 (14.5)</td>
###xml 2021 2030 2021 2030 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">13 (17.6)</td>
###xml 2030 2038 2030 2038 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">6 (28.6)</td>
###xml 2038 2046 2038 2046 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7 (13.2)</td>
###xml 2010 2046 2010 2046 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">61</td><td char="(" align="char">23 (14.5)</td><td char="(" align="char">13 (17.6)</td><td char="(" align="char">6 (28.6)</td><td char="(" align="char">7 (13.2)</td></tr>
###xml 2046 2048 2046 2048 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">62</td>
###xml 2048 2057 2048 2057 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">29 (18.2)</td>
###xml 2057 2066 2057 2066 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">14 (18.9)</td>
###xml 2066 2073 2066 2073 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (4.8)</td>
###xml 2073 2082 2073 2082 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">13 (24.5)</td>
###xml 2046 2082 2046 2082 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">62</td><td char="(" align="char">29 (18.2)</td><td char="(" align="char">14 (18.9)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">13 (24.5)</td></tr>
###xml 2082 2084 2082 2084 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">67</td>
###xml 2084 2091 2084 2091 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">4 (2.5)</td>
###xml 2091 2098 2091 2098 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (2.7)</td>
###xml 2098 2105 2098 2105 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (4.8)</td>
###xml 2105 2112 2105 2112 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (1.9)</td>
###xml 2082 2112 2082 2112 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">67</td><td char="(" align="char">4 (2.5)</td><td char="(" align="char">2 (2.7)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">1 (1.9)</td></tr>
###xml 2112 2114 2112 2114 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">71</td>
###xml 2114 2121 2114 2121 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7 (4.4)</td>
###xml 2121 2128 2121 2128 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (1.4)</td>
###xml 2128 2135 2128 2135 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 2135 2142 2135 2142 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (1.9)</td>
###xml 2112 2142 2112 2142 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">71</td><td char="(" align="char">7 (4.4)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr>
###xml 2142 2144 2142 2144 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">75</td>
###xml 2144 2151 2144 2151 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (1.3)</td>
###xml 2158 2159 2158 2159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 2151 2159 2151 2159 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7 (9.5)<sup>c</sup></td>
###xml 2159 2166 2159 2166 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 2174 2175 2174 2175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 2166 2175 2166 2175 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7 (13.2)<sup>d</sup></td>
###xml 2142 2175 2142 2175 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">75</td><td char="(" align="char">2 (1.3)</td><td char="(" align="char">7 (9.5)<sup>c</sup></td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">7 (13.2)<sup>d</sup></td></tr>
###xml 1306 2175 1306 2175 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left" colspan="5">HLA-B</td></tr><tr><td align="left">07</td><td char="(" align="char">19 (11.9)</td><td char="(" align="char">9 (12.2)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">6 (11.3)</td></tr><tr><td align="left">08</td><td char="(" align="char">2 (1.3)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td></tr><tr><td align="left">13</td><td char="(" align="char">20 (12.6)</td><td char="(" align="char">5 (6.8)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">3 (5.7)</td></tr><tr><td align="left">14</td><td char="(" align="char">6 (3.8)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td></tr><tr><td align="left">27</td><td char="(" align="char">11 (6.9)</td><td char="(" align="char">3 (4.1)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">2 (3.8)</td></tr><tr><td align="left">35</td><td char="(" align="char">11 (6.9)</td><td char="(" align="char">14 (18.9)<sup>a</sup></td><td char="(" align="char">4 (19.0)</td><td char="(" align="char">10 (18.9)<sup>b</sup></td></tr><tr><td align="left">37</td><td char="(" align="char">5 (3.1)</td><td char="(" align="char">4 (5.4)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">2 (3.8)</td></tr><tr><td align="left">38</td><td char="(" align="char">7 (4.4)</td><td char="(" align="char">3 (4.1)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">3 (5.7)</td></tr><tr><td align="left">39</td><td char="(" align="char">2 (1.3)</td><td char="(" align="char">3 (4.1)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">44</td><td char="(" align="char">29 (18.2)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">46</td><td char="(" align="char">18 (11.3)</td><td char="(" align="char">7 (9.5)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">5 (9.4)</td></tr><tr><td align="left">47</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">48</td><td char="(" align="char">13 (8.2)</td><td char="(" align="char">2 (2.7)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">2 (3.8)</td></tr><tr><td align="left">51</td><td char="(" align="char">29 (18.2)</td><td char="(" align="char">13 (17.6)</td><td char="(" align="char">5 (23.8)</td><td char="(" align="char">8 (15.1)</td></tr><tr><td align="left">52</td><td char="(" align="char">9 (5.7)</td><td char="(" align="char">3 (4.1)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">54</td><td char="(" align="char">23 (14.5)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">55</td><td char="(" align="char">3 (1.9)</td><td char="(" align="char">4 (5.4)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">3 (5.7)</td></tr><tr><td align="left">56</td><td char="(" align="char">2 (1.3)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td></tr><tr><td align="left">57</td><td char="(" align="char">2 (1.3)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">58</td><td char="(" align="char">15 (9.4)</td><td char="(" align="char">5 (6.8)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">5 (9.4)</td></tr><tr><td align="left">59</td><td char="(" align="char">4 (2.5)</td><td char="(" align="char">3 (4.1)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">3 (5.7)</td></tr><tr><td align="left">60</td><td char="(" align="char">11 (6.9)</td><td char="(" align="char">7 (9.5)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">5 (9.4)</td></tr><tr><td align="left">61</td><td char="(" align="char">23 (14.5)</td><td char="(" align="char">13 (17.6)</td><td char="(" align="char">6 (28.6)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">62</td><td char="(" align="char">29 (18.2)</td><td char="(" align="char">14 (18.9)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">13 (24.5)</td></tr><tr><td align="left">67</td><td char="(" align="char">4 (2.5)</td><td char="(" align="char">2 (2.7)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">71</td><td char="(" align="char">7 (4.4)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">75</td><td char="(" align="char">2 (1.3)</td><td char="(" align="char">7 (9.5)<sup>c</sup></td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">7 (13.2)<sup>d</sup></td></tr></tbody>
###xml 1172 2175 1172 2175 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">HLA alleles</th><th align="left" rowspan="2">Healthy controls (<italic>n</italic> = 159) <italic>n</italic> (%)</th><th align="left" rowspan="2">KD patients (<italic>n</italic> = 74) <italic>n</italic> (%)</th><th align="left" colspan="2">Coronary complications</th></tr><tr><th align="left">Present (<italic>n</italic> = 21) <italic>n</italic> (%)</th><th align="left">Absent (<italic>n</italic> = 53) <italic>n</italic> (%)</th></tr></thead><tbody><tr><td align="left" colspan="5">HLA-B</td></tr><tr><td align="left">07</td><td char="(" align="char">19 (11.9)</td><td char="(" align="char">9 (12.2)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">6 (11.3)</td></tr><tr><td align="left">08</td><td char="(" align="char">2 (1.3)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td></tr><tr><td align="left">13</td><td char="(" align="char">20 (12.6)</td><td char="(" align="char">5 (6.8)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">3 (5.7)</td></tr><tr><td align="left">14</td><td char="(" align="char">6 (3.8)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td></tr><tr><td align="left">27</td><td char="(" align="char">11 (6.9)</td><td char="(" align="char">3 (4.1)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">2 (3.8)</td></tr><tr><td align="left">35</td><td char="(" align="char">11 (6.9)</td><td char="(" align="char">14 (18.9)<sup>a</sup></td><td char="(" align="char">4 (19.0)</td><td char="(" align="char">10 (18.9)<sup>b</sup></td></tr><tr><td align="left">37</td><td char="(" align="char">5 (3.1)</td><td char="(" align="char">4 (5.4)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">2 (3.8)</td></tr><tr><td align="left">38</td><td char="(" align="char">7 (4.4)</td><td char="(" align="char">3 (4.1)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">3 (5.7)</td></tr><tr><td align="left">39</td><td char="(" align="char">2 (1.3)</td><td char="(" align="char">3 (4.1)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">44</td><td char="(" align="char">29 (18.2)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">46</td><td char="(" align="char">18 (11.3)</td><td char="(" align="char">7 (9.5)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">5 (9.4)</td></tr><tr><td align="left">47</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">48</td><td char="(" align="char">13 (8.2)</td><td char="(" align="char">2 (2.7)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">2 (3.8)</td></tr><tr><td align="left">51</td><td char="(" align="char">29 (18.2)</td><td char="(" align="char">13 (17.6)</td><td char="(" align="char">5 (23.8)</td><td char="(" align="char">8 (15.1)</td></tr><tr><td align="left">52</td><td char="(" align="char">9 (5.7)</td><td char="(" align="char">3 (4.1)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">54</td><td char="(" align="char">23 (14.5)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">55</td><td char="(" align="char">3 (1.9)</td><td char="(" align="char">4 (5.4)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">3 (5.7)</td></tr><tr><td align="left">56</td><td char="(" align="char">2 (1.3)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td></tr><tr><td align="left">57</td><td char="(" align="char">2 (1.3)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">58</td><td char="(" align="char">15 (9.4)</td><td char="(" align="char">5 (6.8)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">5 (9.4)</td></tr><tr><td align="left">59</td><td char="(" align="char">4 (2.5)</td><td char="(" align="char">3 (4.1)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">3 (5.7)</td></tr><tr><td align="left">60</td><td char="(" align="char">11 (6.9)</td><td char="(" align="char">7 (9.5)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">5 (9.4)</td></tr><tr><td align="left">61</td><td char="(" align="char">23 (14.5)</td><td char="(" align="char">13 (17.6)</td><td char="(" align="char">6 (28.6)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">62</td><td char="(" align="char">29 (18.2)</td><td char="(" align="char">14 (18.9)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">13 (24.5)</td></tr><tr><td align="left">67</td><td char="(" align="char">4 (2.5)</td><td char="(" align="char">2 (2.7)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">71</td><td char="(" align="char">7 (4.4)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">75</td><td char="(" align="char">2 (1.3)</td><td char="(" align="char">7 (9.5)<sup>c</sup></td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">7 (13.2)<sup>d</sup></td></tr></tbody></table>
###xml 2175 2214 2175 2214 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="41">KD, Kawasaki disease; RR, relative risk</p>
###xml 2214 2215 2214 2215 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 2215 2216 2215 2216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2214 2304 2214 2304 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="42"><sup>a</sup><italic>p</italic> &lt; 0.006; RR = 3.1 (95% confidence interval [CI], 1.29&#8211;7.62) vs healthy control subjects</p>
###xml 2304 2305 2304 2305 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 2305 2306 2305 2306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2304 2371 2304 2371 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="43"><sup>b</sup><italic>p</italic> &lt; 0.02; RR = 3.1 (95% CI, 1.16&#8211;8.43) vs healthy control subjects</p>
###xml 2371 2372 2371 2372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 2372 2373 2372 2373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2371 2439 2371 2439 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="44"><sup>c</sup><italic>p</italic> &lt; 0.02; RR = 8.2 (95% CI, 1.74&#8211;38.68) vs healthy control subjects</p>
###xml 2439 2440 2439 2440 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 2440 2441 2440 2441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2439 2507 2439 2507 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="45"><sup>d</sup><italic>p</italic> &lt; 0.003; RR = 11 (95% CI, 2.79&#8211;51.13) vs healthy control subjects</p>
###xml 2175 2507 2175 2507 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="41">KD, Kawasaki disease; RR, relative risk</p><p textid="42"><sup>a</sup><italic>p</italic> &lt; 0.006; RR = 3.1 (95% confidence interval [CI], 1.29&#8211;7.62) vs healthy control subjects</p><p textid="43"><sup>b</sup><italic>p</italic> &lt; 0.02; RR = 3.1 (95% CI, 1.16&#8211;8.43) vs healthy control subjects</p><p textid="44"><sup>c</sup><italic>p</italic> &lt; 0.02; RR = 8.2 (95% CI, 1.74&#8211;38.68) vs healthy control subjects</p><p textid="45"><sup>d</sup><italic>p</italic> &lt; 0.003; RR = 11 (95% CI, 2.79&#8211;51.13) vs healthy control subjects</p></table-wrap-foot>
###xml 1043 2507 1043 2507 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab3"><label>Table&#160;3</label><caption><p textid="40">The allele frequencies of human leukocyte antigen-B (HLA-B) in the patients with Kawasaki disease and the control subjects</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">HLA alleles</th><th align="left" rowspan="2">Healthy controls (<italic>n</italic> = 159) <italic>n</italic> (%)</th><th align="left" rowspan="2">KD patients (<italic>n</italic> = 74) <italic>n</italic> (%)</th><th align="left" colspan="2">Coronary complications</th></tr><tr><th align="left">Present (<italic>n</italic> = 21) <italic>n</italic> (%)</th><th align="left">Absent (<italic>n</italic> = 53) <italic>n</italic> (%)</th></tr></thead><tbody><tr><td align="left" colspan="5">HLA-B</td></tr><tr><td align="left">07</td><td char="(" align="char">19 (11.9)</td><td char="(" align="char">9 (12.2)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">6 (11.3)</td></tr><tr><td align="left">08</td><td char="(" align="char">2 (1.3)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td></tr><tr><td align="left">13</td><td char="(" align="char">20 (12.6)</td><td char="(" align="char">5 (6.8)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">3 (5.7)</td></tr><tr><td align="left">14</td><td char="(" align="char">6 (3.8)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td></tr><tr><td align="left">27</td><td char="(" align="char">11 (6.9)</td><td char="(" align="char">3 (4.1)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">2 (3.8)</td></tr><tr><td align="left">35</td><td char="(" align="char">11 (6.9)</td><td char="(" align="char">14 (18.9)<sup>a</sup></td><td char="(" align="char">4 (19.0)</td><td char="(" align="char">10 (18.9)<sup>b</sup></td></tr><tr><td align="left">37</td><td char="(" align="char">5 (3.1)</td><td char="(" align="char">4 (5.4)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">2 (3.8)</td></tr><tr><td align="left">38</td><td char="(" align="char">7 (4.4)</td><td char="(" align="char">3 (4.1)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">3 (5.7)</td></tr><tr><td align="left">39</td><td char="(" align="char">2 (1.3)</td><td char="(" align="char">3 (4.1)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">44</td><td char="(" align="char">29 (18.2)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">46</td><td char="(" align="char">18 (11.3)</td><td char="(" align="char">7 (9.5)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">5 (9.4)</td></tr><tr><td align="left">47</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">48</td><td char="(" align="char">13 (8.2)</td><td char="(" align="char">2 (2.7)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">2 (3.8)</td></tr><tr><td align="left">51</td><td char="(" align="char">29 (18.2)</td><td char="(" align="char">13 (17.6)</td><td char="(" align="char">5 (23.8)</td><td char="(" align="char">8 (15.1)</td></tr><tr><td align="left">52</td><td char="(" align="char">9 (5.7)</td><td char="(" align="char">3 (4.1)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">54</td><td char="(" align="char">23 (14.5)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">55</td><td char="(" align="char">3 (1.9)</td><td char="(" align="char">4 (5.4)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">3 (5.7)</td></tr><tr><td align="left">56</td><td char="(" align="char">2 (1.3)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">0 (0.0)</td></tr><tr><td align="left">57</td><td char="(" align="char">2 (1.3)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">58</td><td char="(" align="char">15 (9.4)</td><td char="(" align="char">5 (6.8)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">5 (9.4)</td></tr><tr><td align="left">59</td><td char="(" align="char">4 (2.5)</td><td char="(" align="char">3 (4.1)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">3 (5.7)</td></tr><tr><td align="left">60</td><td char="(" align="char">11 (6.9)</td><td char="(" align="char">7 (9.5)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">5 (9.4)</td></tr><tr><td align="left">61</td><td char="(" align="char">23 (14.5)</td><td char="(" align="char">13 (17.6)</td><td char="(" align="char">6 (28.6)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">62</td><td char="(" align="char">29 (18.2)</td><td char="(" align="char">14 (18.9)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">13 (24.5)</td></tr><tr><td align="left">67</td><td char="(" align="char">4 (2.5)</td><td char="(" align="char">2 (2.7)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">71</td><td char="(" align="char">7 (4.4)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">75</td><td char="(" align="char">2 (1.3)</td><td char="(" align="char">7 (9.5)<sup>c</sup></td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">7 (13.2)<sup>d</sup></td></tr></tbody></table><table-wrap-foot><p textid="41">KD, Kawasaki disease; RR, relative risk</p><p textid="42"><sup>a</sup><italic>p</italic> &lt; 0.006; RR = 3.1 (95% confidence interval [CI], 1.29&#8211;7.62) vs healthy control subjects</p><p textid="43"><sup>b</sup><italic>p</italic> &lt; 0.02; RR = 3.1 (95% CI, 1.16&#8211;8.43) vs healthy control subjects</p><p textid="44"><sup>c</sup><italic>p</italic> &lt; 0.02; RR = 8.2 (95% CI, 1.74&#8211;38.68) vs healthy control subjects</p><p textid="45"><sup>d</sup><italic>p</italic> &lt; 0.003; RR = 11 (95% CI, 2.79&#8211;51.13) vs healthy control subjects</p></table-wrap-foot></table-wrap>
###xml 136 144 <span type="species:ncbi:9606">patients</span>
###xml 253 261 <span type="species:ncbi:9606">patients</span>
###xml 358 366 <span type="species:ncbi:9606">patients</span>
###xml 710 718 <span type="species:ncbi:9606">patients</span>
###xml 1076 1081 <span type="species:ncbi:9606">human</span>
###xml 1117 1125 <span type="species:ncbi:9606">patients</span>
###xml 1218 1226 <span type="species:ncbi:9606">patients</span>
In analysis of the polymorphisms of HLA-B alleles, there was a significant increase in the frequency of HLA-B35 and -B75 alleles in the patients with Kawasaki disease compared with the control group (p < 0.006; RR = 3.1 vs p < 0.02; RR = 8.2). When the patients with Kawasaki disease were divided into two subgroups, with or without CC, the Kawasaki disease patients without CC showed a significantly increased frequency of HLA-B35 and -B75 alleles compared with the healthy control group (p < 0.02; RR = 3.1 vs p < 0.003; RR = 11) (Table 3). Although the frequency of the HLA-B35 alleles were similar in the groups with and without CC (19% vs 18.9%), the HLA-B75 allele was found only in the Kawasaki disease patients without CC (0.0% vs. 13.2%). Therefore, the HLA-B35 allele was implicated in susceptibility to Kawasaki disease and the HLA-B75 allele in susceptibility to Kawasaki disease without CC. In a comparison between the subgroups, with and without CC, there was no overall significant difference identified between the two groups. Table 3The allele frequencies of human leukocyte antigen-B (HLA-B) in the patients with Kawasaki disease and the control subjectsHLA allelesHealthy controls (n = 159) n (%)KD patients (n = 74) n (%)Coronary complicationsPresent (n = 21) n (%)Absent (n = 53) n (%)HLA-B0719 (11.9)9 (12.2)3 (14.3)6 (11.3)082 (1.3)0 (0.0)0 (0.0)0 (0.0)1320 (12.6)5 (6.8)2 (9.5)3 (5.7)146 (3.8)0 (0.0)0 (0.0)0 (0.0)2711 (6.9)3 (4.1)1 (4.8)2 (3.8)3511 (6.9)14 (18.9)a4 (19.0)10 (18.9)b375 (3.1)4 (5.4)2 (9.5)2 (3.8)387 (4.4)3 (4.1)0 (0.0)3 (5.7)392 (1.3)3 (4.1)2 (9.5)1 (1.9)4429 (18.2)10 (13.5)3 (14.3)7 (13.2)4618 (11.3)7 (9.5)2 (9.5)5 (9.4)470 (0.0)1 (1.4)0 (0.0)1 (1.9)4813 (8.2)2 (2.7)0 (0.0)2 (3.8)5129 (18.2)13 (17.6)5 (23.8)8 (15.1)529 (5.7)3 (4.1)2 (9.5)1 (1.9)5423 (14.5)10 (13.5)3 (14.3)7 (13.2)553 (1.9)4 (5.4)1 (4.8)3 (5.7)562 (1.3)0 (0.0)0 (0.0)0 (0.0)572 (1.3)1 (1.4)0 (0.0)1 (1.9)5815 (9.4)5 (6.8)0 (0.0)5 (9.4)594 (2.5)3 (4.1)0 (0.0)3 (5.7)6011 (6.9)7 (9.5)2 (9.5)5 (9.4)6123 (14.5)13 (17.6)6 (28.6)7 (13.2)6229 (18.2)14 (18.9)1 (4.8)13 (24.5)674 (2.5)2 (2.7)1 (4.8)1 (1.9)717 (4.4)1 (1.4)0 (0.0)1 (1.9)752 (1.3)7 (9.5)c0 (0.0)7 (13.2)dKD, Kawasaki disease; RR, relative riskap < 0.006; RR = 3.1 (95% confidence interval [CI], 1.29-7.62) vs healthy control subjectsbp < 0.02; RR = 3.1 (95% CI, 1.16-8.43) vs healthy control subjectscp < 0.02; RR = 8.2 (95% CI, 1.74-38.68) vs healthy control subjectsdp < 0.003; RR = 11 (95% CI, 2.79-51.13) vs healthy control subjects
###end p 39
###begin p 40
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 67 75 <span type="species:ncbi:9606">patients</span>
The allele frequencies of human leukocyte antigen-B (HLA-B) in the patients with Kawasaki disease and the control subjects
###end p 40
###begin p 41
KD, Kawasaki disease; RR, relative risk
###end p 41
###begin p 42
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
ap < 0.006; RR = 3.1 (95% confidence interval [CI], 1.29-7.62) vs healthy control subjects
###end p 42
###begin p 43
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
bp < 0.02; RR = 3.1 (95% CI, 1.16-8.43) vs healthy control subjects
###end p 43
###begin p 44
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
cp < 0.02; RR = 8.2 (95% CI, 1.74-38.68) vs healthy control subjects
###end p 44
###begin p 45
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
dp < 0.003; RR = 11 (95% CI, 2.79-51.13) vs healthy control subjects
###end p 45
###begin title 46
###xml 64 72 <span type="species:ncbi:9606">Patients</span>
The Genotype Distribution and Allele Frequency of HLA-C for the Patients With Kawasaki Disease and the Healthy Control Group
###end title 46
###begin p 47
###xml 207 208 207 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 464 465 464 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 579 580 579 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab4" ref-type="table">4</xref>
###xml 583 590 583 590 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;4</label>
###xml 590 712 590 712 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="48">The allele frequencies of human leukocyte antigen-C (HLA-C) in the patients with Kawasaki disease and the control subjects</p>
###xml 590 712 590 712 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="48">The allele frequencies of human leukocyte antigen-C (HLA-C) in the patients with Kawasaki disease and the control subjects</p></caption>
###xml 712 723 712 723 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">HLA alleles</th>
###xml 741 742 741 742 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 750 751 750 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 723 755 723 755 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">Healthy controls (<italic>n</italic> = 159) <italic>n</italic> (%)</th>
###xml 768 769 768 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 776 777 776 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 755 781 755 781 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">KD patients (<italic>n</italic> = 74) <italic>n</italic> (%)</th>
###xml 781 803 781 803 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">Coronary complications</th>
###xml 712 803 712 803 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="2">HLA alleles</th><th align="left" rowspan="2">Healthy controls (<italic>n</italic> = 159) <italic>n</italic> (%)</th><th align="left" rowspan="2">KD patients (<italic>n</italic> = 74) <italic>n</italic> (%)</th><th align="left" colspan="2">Coronary complications</th></tr>
###xml 812 813 812 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 820 821 820 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 803 825 803 825 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Present (<italic>n</italic> = 21) <italic>n</italic> (%)</th>
###xml 833 834 833 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 841 842 841 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 825 846 825 846 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Absent (<italic>n</italic> = 53) <italic>n</italic> (%)</th>
###xml 803 846 803 846 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Present (<italic>n</italic> = 21) <italic>n</italic> (%)</th><th align="left">Absent (<italic>n</italic> = 53) <italic>n</italic> (%)</th></tr>
###xml 712 846 712 846 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="2">HLA alleles</th><th align="left" rowspan="2">Healthy controls (<italic>n</italic> = 159) <italic>n</italic> (%)</th><th align="left" rowspan="2">KD patients (<italic>n</italic> = 74) <italic>n</italic> (%)</th><th align="left" colspan="2">Coronary complications</th></tr><tr><th align="left">Present (<italic>n</italic> = 21) <italic>n</italic> (%)</th><th align="left">Absent (<italic>n</italic> = 53) <italic>n</italic> (%)</th></tr></thead>
###xml 846 852 846 852 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="5">HLA-Cw</td>
###xml 846 852 846 852 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="5">HLA-Cw</td></tr>
###xml 852 854 852 854 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">01</td>
###xml 854 863 854 863 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">59 (37.1)</td>
###xml 863 872 863 872 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">22 (29.7)</td>
###xml 872 880 872 880 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">6 (28.6)</td>
###xml 880 889 880 889 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">16 (30.2)</td>
###xml 852 889 852 889 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">01</td><td char="(" align="char">59 (37.1)</td><td char="(" align="char">22 (29.7)</td><td char="(" align="char">6 (28.6)</td><td char="(" align="char">16 (30.2)</td></tr>
###xml 889 891 889 891 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">02</td>
###xml 891 898 891 898 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 898 905 898 905 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (1.4)</td>
###xml 905 912 905 912 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 912 919 912 919 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (1.9)</td>
###xml 889 919 889 919 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">02</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr>
###xml 919 921 919 921 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">04</td>
###xml 921 930 921 930 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">21 (13.2)</td>
###xml 930 939 930 939 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">11 (14.9)</td>
###xml 939 946 939 946 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (9.5)</td>
###xml 946 954 946 954 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">9 (17.0)</td>
###xml 919 954 919 954 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">04</td><td char="(" align="char">21 (13.2)</td><td char="(" align="char">11 (14.9)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">9 (17.0)</td></tr>
###xml 954 956 954 956 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">05</td>
###xml 956 963 956 963 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">6 (3.8)</td>
###xml 963 970 963 970 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (1.4)</td>
###xml 970 977 970 977 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 977 984 977 984 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (1.9)</td>
###xml 954 984 954 984 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">05</td><td char="(" align="char">6 (3.8)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr>
###xml 984 986 984 986 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">06</td>
###xml 986 995 986 995 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">25 (15.7)</td>
###xml 995 1004 995 1004 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">10 (13.5)</td>
###xml 1004 1012 1004 1012 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5 (23.8)</td>
###xml 1012 1019 1012 1019 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5 (9.4)</td>
###xml 984 1019 984 1019 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">06</td><td char="(" align="char">25 (15.7)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">5 (23.8)</td><td char="(" align="char">5 (9.4)</td></tr>
###xml 1019 1021 1019 1021 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">07</td>
###xml 1021 1030 1021 1030 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">44 (27.7)</td>
###xml 1030 1039 1030 1039 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">20 (27.0)</td>
###xml 1039 1047 1039 1047 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">6 (28.6)</td>
###xml 1047 1056 1047 1056 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">14 (26.4)</td>
###xml 1019 1056 1019 1056 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">07</td><td char="(" align="char">44 (27.7)</td><td char="(" align="char">20 (27.0)</td><td char="(" align="char">6 (28.6)</td><td char="(" align="char">14 (26.4)</td></tr>
###xml 1056 1058 1056 1058 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">08</td>
###xml 1058 1067 1058 1067 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">29 (18.2)</td>
###xml 1067 1076 1067 1076 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">10 (13.5)</td>
###xml 1076 1084 1076 1084 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (14.3)</td>
###xml 1084 1092 1084 1092 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7 (13.2)</td>
###xml 1056 1092 1056 1092 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">08</td><td char="(" align="char">29 (18.2)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">7 (13.2)</td></tr>
###xml 1092 1094 1092 1094 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">09</td>
###xml 1094 1103 1094 1103 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">23 (14.5)</td>
###xml 1112 1113 1112 1113 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1103 1113 1103 1113 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">19 (25.7)<sup>a</sup></td>
###xml 1113 1121 1113 1121 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5 (23.8)</td>
###xml 1130 1131 1130 1131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1121 1131 1121 1131 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">14 (26.4)<sup>b</sup></td>
###xml 1092 1131 1092 1131 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">09</td><td char="(" align="char">23 (14.5)</td><td char="(" align="char">19 (25.7)<sup>a</sup></td><td char="(" align="char">5 (23.8)</td><td char="(" align="char">14 (26.4)<sup>b</sup></td></tr>
###xml 1131 1133 1131 1133 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">10</td>
###xml 1133 1142 1133 1142 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">39 (24.5)</td>
###xml 1142 1151 1142 1151 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">24 (32.4)</td>
###xml 1151 1159 1151 1159 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5 (23.8)</td>
###xml 1159 1168 1159 1168 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">19 (35.8)</td>
###xml 1131 1168 1131 1168 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">10</td><td char="(" align="char">39 (24.5)</td><td char="(" align="char">24 (32.4)</td><td char="(" align="char">5 (23.8)</td><td char="(" align="char">19 (35.8)</td></tr>
###xml 1168 1170 1168 1170 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">12</td>
###xml 1170 1178 1170 1178 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">11 (6.9)</td>
###xml 1178 1185 1178 1185 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">4 (5.4)</td>
###xml 1185 1192 1185 1192 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (9.5)</td>
###xml 1192 1199 1192 1199 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (3.8)</td>
###xml 1168 1199 1168 1199 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">12</td><td char="(" align="char">11 (6.9)</td><td char="(" align="char">4 (5.4)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">2 (3.8)</td></tr>
###xml 1199 1201 1199 1201 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">14</td>
###xml 1201 1210 1201 1210 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">34 (21.4)</td>
###xml 1210 1219 1210 1219 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">18 (24.3)</td>
###xml 1219 1227 1219 1227 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7 (33.3)</td>
###xml 1227 1236 1227 1236 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">11 (20.8)</td>
###xml 1199 1236 1199 1236 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">14</td><td char="(" align="char">34 (21.4)</td><td char="(" align="char">18 (24.3)</td><td char="(" align="char">7 (33.3)</td><td char="(" align="char">11 (20.8)</td></tr>
###xml 1236 1238 1236 1238 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">15</td>
###xml 1238 1245 1238 1245 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">8 (5.0)</td>
###xml 1245 1252 1245 1252 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (1.4)</td>
###xml 1252 1259 1252 1259 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (4.8)</td>
###xml 1259 1266 1259 1266 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 1236 1266 1236 1266 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">15</td><td char="(" align="char">8 (5.0)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">0 (0.0)</td></tr>
###xml 846 1266 846 1266 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left" colspan="5">HLA-Cw</td></tr><tr><td align="left">01</td><td char="(" align="char">59 (37.1)</td><td char="(" align="char">22 (29.7)</td><td char="(" align="char">6 (28.6)</td><td char="(" align="char">16 (30.2)</td></tr><tr><td align="left">02</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">04</td><td char="(" align="char">21 (13.2)</td><td char="(" align="char">11 (14.9)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">9 (17.0)</td></tr><tr><td align="left">05</td><td char="(" align="char">6 (3.8)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">06</td><td char="(" align="char">25 (15.7)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">5 (23.8)</td><td char="(" align="char">5 (9.4)</td></tr><tr><td align="left">07</td><td char="(" align="char">44 (27.7)</td><td char="(" align="char">20 (27.0)</td><td char="(" align="char">6 (28.6)</td><td char="(" align="char">14 (26.4)</td></tr><tr><td align="left">08</td><td char="(" align="char">29 (18.2)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">09</td><td char="(" align="char">23 (14.5)</td><td char="(" align="char">19 (25.7)<sup>a</sup></td><td char="(" align="char">5 (23.8)</td><td char="(" align="char">14 (26.4)<sup>b</sup></td></tr><tr><td align="left">10</td><td char="(" align="char">39 (24.5)</td><td char="(" align="char">24 (32.4)</td><td char="(" align="char">5 (23.8)</td><td char="(" align="char">19 (35.8)</td></tr><tr><td align="left">12</td><td char="(" align="char">11 (6.9)</td><td char="(" align="char">4 (5.4)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">2 (3.8)</td></tr><tr><td align="left">14</td><td char="(" align="char">34 (21.4)</td><td char="(" align="char">18 (24.3)</td><td char="(" align="char">7 (33.3)</td><td char="(" align="char">11 (20.8)</td></tr><tr><td align="left">15</td><td char="(" align="char">8 (5.0)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">0 (0.0)</td></tr></tbody>
###xml 712 1266 712 1266 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">HLA alleles</th><th align="left" rowspan="2">Healthy controls (<italic>n</italic> = 159) <italic>n</italic> (%)</th><th align="left" rowspan="2">KD patients (<italic>n</italic> = 74) <italic>n</italic> (%)</th><th align="left" colspan="2">Coronary complications</th></tr><tr><th align="left">Present (<italic>n</italic> = 21) <italic>n</italic> (%)</th><th align="left">Absent (<italic>n</italic> = 53) <italic>n</italic> (%)</th></tr></thead><tbody><tr><td align="left" colspan="5">HLA-Cw</td></tr><tr><td align="left">01</td><td char="(" align="char">59 (37.1)</td><td char="(" align="char">22 (29.7)</td><td char="(" align="char">6 (28.6)</td><td char="(" align="char">16 (30.2)</td></tr><tr><td align="left">02</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">04</td><td char="(" align="char">21 (13.2)</td><td char="(" align="char">11 (14.9)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">9 (17.0)</td></tr><tr><td align="left">05</td><td char="(" align="char">6 (3.8)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">06</td><td char="(" align="char">25 (15.7)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">5 (23.8)</td><td char="(" align="char">5 (9.4)</td></tr><tr><td align="left">07</td><td char="(" align="char">44 (27.7)</td><td char="(" align="char">20 (27.0)</td><td char="(" align="char">6 (28.6)</td><td char="(" align="char">14 (26.4)</td></tr><tr><td align="left">08</td><td char="(" align="char">29 (18.2)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">09</td><td char="(" align="char">23 (14.5)</td><td char="(" align="char">19 (25.7)<sup>a</sup></td><td char="(" align="char">5 (23.8)</td><td char="(" align="char">14 (26.4)<sup>b</sup></td></tr><tr><td align="left">10</td><td char="(" align="char">39 (24.5)</td><td char="(" align="char">24 (32.4)</td><td char="(" align="char">5 (23.8)</td><td char="(" align="char">19 (35.8)</td></tr><tr><td align="left">12</td><td char="(" align="char">11 (6.9)</td><td char="(" align="char">4 (5.4)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">2 (3.8)</td></tr><tr><td align="left">14</td><td char="(" align="char">34 (21.4)</td><td char="(" align="char">18 (24.3)</td><td char="(" align="char">7 (33.3)</td><td char="(" align="char">11 (20.8)</td></tr><tr><td align="left">15</td><td char="(" align="char">8 (5.0)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">0 (0.0)</td></tr></tbody></table>
###xml 1266 1305 1266 1305 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="49">KD, Kawasaki disease; RR, relative risk</p>
###xml 1305 1306 1305 1306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1306 1307 1306 1307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1305 1394 1305 1394 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="50"><sup>a</sup><italic>p</italic> &lt; 0.04; RR = 2.0 (95% confidence interval [CI], 0.97&#8211;4.29) vs healthy control subjects</p>
###xml 1394 1395 1394 1395 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1395 1396 1395 1396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1394 1461 1394 1461 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="51"><sup>b</sup><italic>p</italic> &lt; 0.05; RR = 2.1 (95% CI, 0.92&#8211;4.87) vs healthy control subjects</p>
###xml 1266 1461 1266 1461 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="49">KD, Kawasaki disease; RR, relative risk</p><p textid="50"><sup>a</sup><italic>p</italic> &lt; 0.04; RR = 2.0 (95% confidence interval [CI], 0.97&#8211;4.29) vs healthy control subjects</p><p textid="51"><sup>b</sup><italic>p</italic> &lt; 0.05; RR = 2.1 (95% CI, 0.92&#8211;4.87) vs healthy control subjects</p></table-wrap-foot>
###xml 583 1461 583 1461 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab4"><label>Table&#160;4</label><caption><p textid="48">The allele frequencies of human leukocyte antigen-C (HLA-C) in the patients with Kawasaki disease and the control subjects</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">HLA alleles</th><th align="left" rowspan="2">Healthy controls (<italic>n</italic> = 159) <italic>n</italic> (%)</th><th align="left" rowspan="2">KD patients (<italic>n</italic> = 74) <italic>n</italic> (%)</th><th align="left" colspan="2">Coronary complications</th></tr><tr><th align="left">Present (<italic>n</italic> = 21) <italic>n</italic> (%)</th><th align="left">Absent (<italic>n</italic> = 53) <italic>n</italic> (%)</th></tr></thead><tbody><tr><td align="left" colspan="5">HLA-Cw</td></tr><tr><td align="left">01</td><td char="(" align="char">59 (37.1)</td><td char="(" align="char">22 (29.7)</td><td char="(" align="char">6 (28.6)</td><td char="(" align="char">16 (30.2)</td></tr><tr><td align="left">02</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">04</td><td char="(" align="char">21 (13.2)</td><td char="(" align="char">11 (14.9)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">9 (17.0)</td></tr><tr><td align="left">05</td><td char="(" align="char">6 (3.8)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">06</td><td char="(" align="char">25 (15.7)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">5 (23.8)</td><td char="(" align="char">5 (9.4)</td></tr><tr><td align="left">07</td><td char="(" align="char">44 (27.7)</td><td char="(" align="char">20 (27.0)</td><td char="(" align="char">6 (28.6)</td><td char="(" align="char">14 (26.4)</td></tr><tr><td align="left">08</td><td char="(" align="char">29 (18.2)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">09</td><td char="(" align="char">23 (14.5)</td><td char="(" align="char">19 (25.7)<sup>a</sup></td><td char="(" align="char">5 (23.8)</td><td char="(" align="char">14 (26.4)<sup>b</sup></td></tr><tr><td align="left">10</td><td char="(" align="char">39 (24.5)</td><td char="(" align="char">24 (32.4)</td><td char="(" align="char">5 (23.8)</td><td char="(" align="char">19 (35.8)</td></tr><tr><td align="left">12</td><td char="(" align="char">11 (6.9)</td><td char="(" align="char">4 (5.4)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">2 (3.8)</td></tr><tr><td align="left">14</td><td char="(" align="char">34 (21.4)</td><td char="(" align="char">18 (24.3)</td><td char="(" align="char">7 (33.3)</td><td char="(" align="char">11 (20.8)</td></tr><tr><td align="left">15</td><td char="(" align="char">8 (5.0)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">0 (0.0)</td></tr></tbody></table><table-wrap-foot><p textid="49">KD, Kawasaki disease; RR, relative risk</p><p textid="50"><sup>a</sup><italic>p</italic> &lt; 0.04; RR = 2.0 (95% confidence interval [CI], 0.97&#8211;4.29) vs healthy control subjects</p><p textid="51"><sup>b</sup><italic>p</italic> &lt; 0.05; RR = 2.1 (95% CI, 0.92&#8211;4.87) vs healthy control subjects</p></table-wrap-foot></table-wrap>
###xml 135 143 <span type="species:ncbi:9606">patients</span>
###xml 254 262 <span type="species:ncbi:9606">patients</span>
###xml 337 345 <span type="species:ncbi:9606">patients</span>
###xml 616 621 <span type="species:ncbi:9606">human</span>
###xml 657 665 <span type="species:ncbi:9606">patients</span>
###xml 758 766 <span type="species:ncbi:9606">patients</span>
In the analysis of the polymorphisms of HLA-C alleles, there was a significant increase in the frequency of the HLA-Cw09 allele in the patients with Kawasaki disease compared with the healthy control group (p < 0.04; RR = 2.0). When the Kawasaki disease patients were divided into two subgroups, with or without CC, the Kawasaki disease patients without CC showed a significantly increased frequency of the HLA-Cw09 allele compared with the healthy control group (p < 0.05; RR = 2.1). However, no significant difference was found between the subgroups with and without CC (Table 4). Table 4The allele frequencies of human leukocyte antigen-C (HLA-C) in the patients with Kawasaki disease and the control subjectsHLA allelesHealthy controls (n = 159) n (%)KD patients (n = 74) n (%)Coronary complicationsPresent (n = 21) n (%)Absent (n = 53) n (%)HLA-Cw0159 (37.1)22 (29.7)6 (28.6)16 (30.2)020 (0.0)1 (1.4)0 (0.0)1 (1.9)0421 (13.2)11 (14.9)2 (9.5)9 (17.0)056 (3.8)1 (1.4)0 (0.0)1 (1.9)0625 (15.7)10 (13.5)5 (23.8)5 (9.4)0744 (27.7)20 (27.0)6 (28.6)14 (26.4)0829 (18.2)10 (13.5)3 (14.3)7 (13.2)0923 (14.5)19 (25.7)a5 (23.8)14 (26.4)b1039 (24.5)24 (32.4)5 (23.8)19 (35.8)1211 (6.9)4 (5.4)2 (9.5)2 (3.8)1434 (21.4)18 (24.3)7 (33.3)11 (20.8)158 (5.0)1 (1.4)1 (4.8)0 (0.0)KD, Kawasaki disease; RR, relative riskap < 0.04; RR = 2.0 (95% confidence interval [CI], 0.97-4.29) vs healthy control subjectsbp < 0.05; RR = 2.1 (95% CI, 0.92-4.87) vs healthy control subjects
###end p 47
###begin p 48
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 67 75 <span type="species:ncbi:9606">patients</span>
The allele frequencies of human leukocyte antigen-C (HLA-C) in the patients with Kawasaki disease and the control subjects
###end p 48
###begin p 49
KD, Kawasaki disease; RR, relative risk
###end p 49
###begin p 50
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
ap < 0.04; RR = 2.0 (95% confidence interval [CI], 0.97-4.29) vs healthy control subjects
###end p 50
###begin p 51
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
bp < 0.05; RR = 2.1 (95% CI, 0.92-4.87) vs healthy control subjects
###end p 51
###begin title 52
###xml 73 81 <span type="species:ncbi:9606">Patients</span>
The Genotype Distribution and the Allele Frequencies of HLA-DRB1 for the Patients With Kawasaki Disease and the Healthy Control Group
###end title 52
###begin p 53
###xml 372 373 372 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 619 620 619 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 912 913 912 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 939 940 939 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab5" ref-type="table">5</xref>
###xml 943 950 943 950 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;5</label>
###xml 950 1078 950 1078 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="54">The allele frequencies of human leukocyte antigen-DRB1 (HLA-DRB1) in the patients with Kawasaki disease and the control subjects</p>
###xml 950 1078 950 1078 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="54">The allele frequencies of human leukocyte antigen-DRB1 (HLA-DRB1) in the patients with Kawasaki disease and the control subjects</p></caption>
###xml 1078 1089 1078 1089 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">HLA alleles</th>
###xml 1107 1108 1107 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1116 1117 1116 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1089 1121 1089 1121 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">Healthy controls (<italic>n</italic> = 159) <italic>n</italic> (%)</th>
###xml 1134 1135 1134 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1142 1143 1142 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1121 1147 1121 1147 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" rowspan="2">KD patients (<italic>n</italic> = 74) <italic>n</italic> (%)</th>
###xml 1147 1169 1147 1169 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="2">Coronary complications</th>
###xml 1078 1169 1078 1169 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left" rowspan="2">HLA alleles</th><th align="left" rowspan="2">Healthy controls (<italic>n</italic> = 159) <italic>n</italic> (%)</th><th align="left" rowspan="2">KD patients (<italic>n</italic> = 74) <italic>n</italic> (%)</th><th align="left" colspan="2">Coronary complications</th></tr>
###xml 1178 1179 1178 1179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1186 1187 1186 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1169 1191 1169 1191 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Present (<italic>n</italic> = 21) <italic>n</italic> (%)</th>
###xml 1199 1200 1199 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1207 1208 1207 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1191 1212 1191 1212 <th xmlns:xlink="http://www.w3.org/1999/xlink" align="left">Absent (<italic>n</italic> = 53) <italic>n</italic> (%)</th>
###xml 1169 1212 1169 1212 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th align="left">Present (<italic>n</italic> = 21) <italic>n</italic> (%)</th><th align="left">Absent (<italic>n</italic> = 53) <italic>n</italic> (%)</th></tr>
###xml 1078 1212 1078 1212 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th align="left" rowspan="2">HLA alleles</th><th align="left" rowspan="2">Healthy controls (<italic>n</italic> = 159) <italic>n</italic> (%)</th><th align="left" rowspan="2">KD patients (<italic>n</italic> = 74) <italic>n</italic> (%)</th><th align="left" colspan="2">Coronary complications</th></tr><tr><th align="left">Present (<italic>n</italic> = 21) <italic>n</italic> (%)</th><th align="left">Absent (<italic>n</italic> = 53) <italic>n</italic> (%)</th></tr></thead>
###xml 1212 1220 1212 1220 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left" colspan="5">HLA-DRB1</td>
###xml 1212 1220 1212 1220 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left" colspan="5">HLA-DRB1</td></tr>
###xml 1220 1222 1220 1222 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">01</td>
###xml 1222 1231 1222 1231 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">29 (18.2)</td>
###xml 1231 1239 1231 1239 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">8 (10.8)</td>
###xml 1239 1246 1239 1246 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (4.8)</td>
###xml 1246 1254 1246 1254 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7 (13.2)</td>
###xml 1220 1254 1220 1254 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">01</td><td char="(" align="char">29 (18.2)</td><td char="(" align="char">8 (10.8)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">7 (13.2)</td></tr>
###xml 1254 1256 1254 1256 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">03</td>
###xml 1256 1263 1256 1263 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7 (4.4)</td>
###xml 1263 1270 1263 1270 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (1.4)</td>
###xml 1270 1277 1270 1277 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">0 (0.0)</td>
###xml 1277 1284 1277 1284 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (1.9)</td>
###xml 1254 1284 1254 1284 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">03</td><td char="(" align="char">7 (4.4)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr>
###xml 1284 1286 1284 1286 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">04</td>
###xml 1286 1295 1286 1295 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">48 (30.2)</td>
###xml 1295 1304 1295 1304 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">30 (40.5)</td>
###xml 1304 1312 1304 1312 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">6 (28.6)</td>
###xml 1321 1322 1321 1322 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1312 1322 1312 1322 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">24 (45.3)<sup>a</sup></td>
###xml 1284 1322 1284 1322 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">04</td><td char="(" align="char">48 (30.2)</td><td char="(" align="char">30 (40.5)</td><td char="(" align="char">6 (28.6)</td><td char="(" align="char">24 (45.3)<sup>a</sup></td></tr>
###xml 1322 1324 1322 1324 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">07</td>
###xml 1324 1333 1324 1333 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">26 (16.4)</td>
###xml 1333 1341 1333 1341 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">8 (10.8)</td>
###xml 1341 1348 1341 1348 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (4.8)</td>
###xml 1348 1356 1348 1356 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7 (13.2)</td>
###xml 1322 1356 1322 1356 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">07</td><td char="(" align="char">26 (16.4)</td><td char="(" align="char">8 (10.8)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">7 (13.2)</td></tr>
###xml 1356 1358 1356 1358 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">08</td>
###xml 1358 1367 1358 1367 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">32 (20.1)</td>
###xml 1367 1376 1367 1376 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">14 (18.9)</td>
###xml 1376 1384 1376 1384 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (14.3)</td>
###xml 1384 1393 1384 1393 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">11 (20.8)</td>
###xml 1356 1393 1356 1393 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">08</td><td char="(" align="char">32 (20.1)</td><td char="(" align="char">14 (18.9)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">11 (20.8)</td></tr>
###xml 1393 1395 1393 1395 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">09</td>
###xml 1395 1404 1395 1404 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">28 (17.6)</td>
###xml 1404 1413 1404 1413 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">12 (16.2)</td>
###xml 1421 1422 1421 1422 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1413 1422 1413 1422 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7 (33.3)<sup>b</sup></td>
###xml 1422 1429 1422 1429 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5 (9.4)</td>
###xml 1393 1429 1393 1429 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">09</td><td char="(" align="char">28 (17.6)</td><td char="(" align="char">12 (16.2)</td><td char="(" align="char">7 (33.3)<sup>b</sup></td><td char="(" align="char">5 (9.4)</td></tr>
###xml 1429 1431 1429 1431 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">10</td>
###xml 1431 1438 1431 1438 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">4 (2.5)</td>
###xml 1438 1445 1438 1445 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">4 (5.4)</td>
###xml 1445 1452 1445 1452 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (9.5)</td>
###xml 1452 1459 1452 1459 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (3.8)</td>
###xml 1429 1459 1429 1459 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">10</td><td char="(" align="char">4 (2.5)</td><td char="(" align="char">4 (5.4)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">2 (3.8)</td></tr>
###xml 1459 1461 1459 1461 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">11</td>
###xml 1461 1469 1461 1469 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">10 (6.3)</td>
###xml 1469 1477 1469 1477 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">8 (10.8)</td>
###xml 1485 1486 1485 1486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 1477 1486 1477 1486 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5 (23.8)<sup>c</sup></td>
###xml 1486 1493 1486 1493 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (5.7)</td>
###xml 1459 1493 1459 1493 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">11</td><td char="(" align="char">10 (6.3)</td><td char="(" align="char">8 (10.8)</td><td char="(" align="char">5 (23.8)<sup>c</sup></td><td char="(" align="char">3 (5.7)</td></tr>
###xml 1493 1495 1493 1495 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">12</td>
###xml 1495 1504 1495 1504 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">18 (11.3)</td>
###xml 1504 1513 1504 1513 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">11 (14.9)</td>
###xml 1513 1520 1513 1520 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (9.5)</td>
###xml 1520 1528 1520 1528 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">9 (17.0)</td>
###xml 1493 1528 1493 1528 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">12</td><td char="(" align="char">18 (11.3)</td><td char="(" align="char">11 (14.9)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">9 (17.0)</td></tr>
###xml 1528 1530 1528 1530 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">13</td>
###xml 1530 1539 1530 1539 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">32 (20.1)</td>
###xml 1539 1548 1539 1548 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">10 (13.5)</td>
###xml 1548 1556 1548 1556 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (14.3)</td>
###xml 1556 1564 1556 1564 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7 (13.2)</td>
###xml 1528 1564 1528 1564 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">13</td><td char="(" align="char">32 (20.1)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">7 (13.2)</td></tr>
###xml 1564 1566 1564 1566 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">14</td>
###xml 1566 1575 1566 1575 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">21 (13.2)</td>
###xml 1575 1584 1575 1584 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">10 (13.5)</td>
###xml 1584 1592 1584 1592 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">3 (14.3)</td>
###xml 1592 1600 1592 1600 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">7 (13.2)</td>
###xml 1564 1600 1564 1600 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">14</td><td char="(" align="char">21 (13.2)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">7 (13.2)</td></tr>
###xml 1600 1602 1600 1602 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">15</td>
###xml 1602 1611 1602 1611 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">35 (22.0)</td>
###xml 1611 1620 1611 1620 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">20 (27.0)</td>
###xml 1620 1628 1620 1628 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">5 (23.8)</td>
###xml 1628 1636 1628 1636 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">15(28.3)</td>
###xml 1600 1636 1600 1636 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">15</td><td char="(" align="char">35 (22.0)</td><td char="(" align="char">20 (27.0)</td><td char="(" align="char">5 (23.8)</td><td char="(" align="char">15(28.3)</td></tr>
###xml 1636 1638 1636 1638 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="left">16</td>
###xml 1638 1645 1638 1645 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">4 (2.5)</td>
###xml 1645 1652 1645 1652 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">2 (2.7)</td>
###xml 1652 1659 1652 1659 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (4.8)</td>
###xml 1659 1666 1659 1666 <td xmlns:xlink="http://www.w3.org/1999/xlink" char="(" align="char">1 (1.9)</td>
###xml 1636 1666 1636 1666 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td align="left">16</td><td char="(" align="char">4 (2.5)</td><td char="(" align="char">2 (2.7)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">1 (1.9)</td></tr>
###xml 1212 1666 1212 1666 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td align="left" colspan="5">HLA-DRB1</td></tr><tr><td align="left">01</td><td char="(" align="char">29 (18.2)</td><td char="(" align="char">8 (10.8)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">03</td><td char="(" align="char">7 (4.4)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">04</td><td char="(" align="char">48 (30.2)</td><td char="(" align="char">30 (40.5)</td><td char="(" align="char">6 (28.6)</td><td char="(" align="char">24 (45.3)<sup>a</sup></td></tr><tr><td align="left">07</td><td char="(" align="char">26 (16.4)</td><td char="(" align="char">8 (10.8)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">08</td><td char="(" align="char">32 (20.1)</td><td char="(" align="char">14 (18.9)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">11 (20.8)</td></tr><tr><td align="left">09</td><td char="(" align="char">28 (17.6)</td><td char="(" align="char">12 (16.2)</td><td char="(" align="char">7 (33.3)<sup>b</sup></td><td char="(" align="char">5 (9.4)</td></tr><tr><td align="left">10</td><td char="(" align="char">4 (2.5)</td><td char="(" align="char">4 (5.4)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">2 (3.8)</td></tr><tr><td align="left">11</td><td char="(" align="char">10 (6.3)</td><td char="(" align="char">8 (10.8)</td><td char="(" align="char">5 (23.8)<sup>c</sup></td><td char="(" align="char">3 (5.7)</td></tr><tr><td align="left">12</td><td char="(" align="char">18 (11.3)</td><td char="(" align="char">11 (14.9)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">9 (17.0)</td></tr><tr><td align="left">13</td><td char="(" align="char">32 (20.1)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">14</td><td char="(" align="char">21 (13.2)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">15</td><td char="(" align="char">35 (22.0)</td><td char="(" align="char">20 (27.0)</td><td char="(" align="char">5 (23.8)</td><td char="(" align="char">15(28.3)</td></tr><tr><td align="left">16</td><td char="(" align="char">4 (2.5)</td><td char="(" align="char">2 (2.7)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">1 (1.9)</td></tr></tbody>
###xml 1078 1666 1078 1666 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">HLA alleles</th><th align="left" rowspan="2">Healthy controls (<italic>n</italic> = 159) <italic>n</italic> (%)</th><th align="left" rowspan="2">KD patients (<italic>n</italic> = 74) <italic>n</italic> (%)</th><th align="left" colspan="2">Coronary complications</th></tr><tr><th align="left">Present (<italic>n</italic> = 21) <italic>n</italic> (%)</th><th align="left">Absent (<italic>n</italic> = 53) <italic>n</italic> (%)</th></tr></thead><tbody><tr><td align="left" colspan="5">HLA-DRB1</td></tr><tr><td align="left">01</td><td char="(" align="char">29 (18.2)</td><td char="(" align="char">8 (10.8)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">03</td><td char="(" align="char">7 (4.4)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">04</td><td char="(" align="char">48 (30.2)</td><td char="(" align="char">30 (40.5)</td><td char="(" align="char">6 (28.6)</td><td char="(" align="char">24 (45.3)<sup>a</sup></td></tr><tr><td align="left">07</td><td char="(" align="char">26 (16.4)</td><td char="(" align="char">8 (10.8)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">08</td><td char="(" align="char">32 (20.1)</td><td char="(" align="char">14 (18.9)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">11 (20.8)</td></tr><tr><td align="left">09</td><td char="(" align="char">28 (17.6)</td><td char="(" align="char">12 (16.2)</td><td char="(" align="char">7 (33.3)<sup>b</sup></td><td char="(" align="char">5 (9.4)</td></tr><tr><td align="left">10</td><td char="(" align="char">4 (2.5)</td><td char="(" align="char">4 (5.4)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">2 (3.8)</td></tr><tr><td align="left">11</td><td char="(" align="char">10 (6.3)</td><td char="(" align="char">8 (10.8)</td><td char="(" align="char">5 (23.8)<sup>c</sup></td><td char="(" align="char">3 (5.7)</td></tr><tr><td align="left">12</td><td char="(" align="char">18 (11.3)</td><td char="(" align="char">11 (14.9)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">9 (17.0)</td></tr><tr><td align="left">13</td><td char="(" align="char">32 (20.1)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">14</td><td char="(" align="char">21 (13.2)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">15</td><td char="(" align="char">35 (22.0)</td><td char="(" align="char">20 (27.0)</td><td char="(" align="char">5 (23.8)</td><td char="(" align="char">15(28.3)</td></tr><tr><td align="left">16</td><td char="(" align="char">4 (2.5)</td><td char="(" align="char">2 (2.7)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">1 (1.9)</td></tr></tbody></table>
###xml 1666 1705 1666 1705 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="55">KD, Kawasaki disease; RR, relative risk</p>
###xml 1705 1706 1705 1706 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1706 1707 1706 1707 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1705 1794 1705 1794 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="56"><sup>a</sup><italic>p</italic> &lt; 0.05; RR = 1.9 (95% confidence interval [CI], 0.96&#8211;3.82) vs healthy control subjects</p>
###xml 1794 1795 1794 1795 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1795 1796 1795 1796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1794 1862 1794 1862 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="57"><sup>b</sup><italic>p</italic> &lt; 0.04 between KD patients with and without coronary complication</p>
###xml 1862 1863 1862 1863 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 1863 1864 1863 1864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1862 1930 1862 1930 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="58"><sup>c</sup><italic>p</italic> &lt; 0.04; RR = 4.7 (95% CI, 1.26&#8211;17.17) vs healthy control subjects</p>
###xml 1666 1930 1666 1930 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="55">KD, Kawasaki disease; RR, relative risk</p><p textid="56"><sup>a</sup><italic>p</italic> &lt; 0.05; RR = 1.9 (95% confidence interval [CI], 0.96&#8211;3.82) vs healthy control subjects</p><p textid="57"><sup>b</sup><italic>p</italic> &lt; 0.04 between KD patients with and without coronary complication</p><p textid="58"><sup>c</sup><italic>p</italic> &lt; 0.04; RR = 4.7 (95% CI, 1.26&#8211;17.17) vs healthy control subjects</p></table-wrap-foot>
###xml 943 1930 943 1930 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab5"><label>Table&#160;5</label><caption><p textid="54">The allele frequencies of human leukocyte antigen-DRB1 (HLA-DRB1) in the patients with Kawasaki disease and the control subjects</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">HLA alleles</th><th align="left" rowspan="2">Healthy controls (<italic>n</italic> = 159) <italic>n</italic> (%)</th><th align="left" rowspan="2">KD patients (<italic>n</italic> = 74) <italic>n</italic> (%)</th><th align="left" colspan="2">Coronary complications</th></tr><tr><th align="left">Present (<italic>n</italic> = 21) <italic>n</italic> (%)</th><th align="left">Absent (<italic>n</italic> = 53) <italic>n</italic> (%)</th></tr></thead><tbody><tr><td align="left" colspan="5">HLA-DRB1</td></tr><tr><td align="left">01</td><td char="(" align="char">29 (18.2)</td><td char="(" align="char">8 (10.8)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">03</td><td char="(" align="char">7 (4.4)</td><td char="(" align="char">1 (1.4)</td><td char="(" align="char">0 (0.0)</td><td char="(" align="char">1 (1.9)</td></tr><tr><td align="left">04</td><td char="(" align="char">48 (30.2)</td><td char="(" align="char">30 (40.5)</td><td char="(" align="char">6 (28.6)</td><td char="(" align="char">24 (45.3)<sup>a</sup></td></tr><tr><td align="left">07</td><td char="(" align="char">26 (16.4)</td><td char="(" align="char">8 (10.8)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">08</td><td char="(" align="char">32 (20.1)</td><td char="(" align="char">14 (18.9)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">11 (20.8)</td></tr><tr><td align="left">09</td><td char="(" align="char">28 (17.6)</td><td char="(" align="char">12 (16.2)</td><td char="(" align="char">7 (33.3)<sup>b</sup></td><td char="(" align="char">5 (9.4)</td></tr><tr><td align="left">10</td><td char="(" align="char">4 (2.5)</td><td char="(" align="char">4 (5.4)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">2 (3.8)</td></tr><tr><td align="left">11</td><td char="(" align="char">10 (6.3)</td><td char="(" align="char">8 (10.8)</td><td char="(" align="char">5 (23.8)<sup>c</sup></td><td char="(" align="char">3 (5.7)</td></tr><tr><td align="left">12</td><td char="(" align="char">18 (11.3)</td><td char="(" align="char">11 (14.9)</td><td char="(" align="char">2 (9.5)</td><td char="(" align="char">9 (17.0)</td></tr><tr><td align="left">13</td><td char="(" align="char">32 (20.1)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">14</td><td char="(" align="char">21 (13.2)</td><td char="(" align="char">10 (13.5)</td><td char="(" align="char">3 (14.3)</td><td char="(" align="char">7 (13.2)</td></tr><tr><td align="left">15</td><td char="(" align="char">35 (22.0)</td><td char="(" align="char">20 (27.0)</td><td char="(" align="char">5 (23.8)</td><td char="(" align="char">15(28.3)</td></tr><tr><td align="left">16</td><td char="(" align="char">4 (2.5)</td><td char="(" align="char">2 (2.7)</td><td char="(" align="char">1 (4.8)</td><td char="(" align="char">1 (1.9)</td></tr></tbody></table><table-wrap-foot><p textid="55">KD, Kawasaki disease; RR, relative risk</p><p textid="56"><sup>a</sup><italic>p</italic> &lt; 0.05; RR = 1.9 (95% confidence interval [CI], 0.96&#8211;3.82) vs healthy control subjects</p><p textid="57"><sup>b</sup><italic>p</italic> &lt; 0.04 between KD patients with and without coronary complication</p><p textid="58"><sup>c</sup><italic>p</italic> &lt; 0.04; RR = 4.7 (95% CI, 1.26&#8211;17.17) vs healthy control subjects</p></table-wrap-foot></table-wrap>
###xml 102 110 <span type="species:ncbi:9606">patients</span>
###xml 203 211 <span type="species:ncbi:9606">patients</span>
###xml 314 322 <span type="species:ncbi:9606">patients</span>
###xml 531 539 <span type="species:ncbi:9606">patients</span>
###xml 583 591 <span type="species:ncbi:9606">patients</span>
###xml 851 859 <span type="species:ncbi:9606">patients</span>
###xml 976 981 <span type="species:ncbi:9606">human</span>
###xml 1023 1031 <span type="species:ncbi:9606">patients</span>
###xml 1124 1132 <span type="species:ncbi:9606">patients</span>
###xml 1815 1823 <span type="species:ncbi:9606">patients</span>
Among the HLA-DRB1 alleles, there was no increase in the frequency of alleles in the Kawasaki disease patients compared with the healthy control group. However, after subgrouping of the Kawasaki disease patients, with or without CC, the frequency of HLA-DRB1*11 was significantly increased in the Kawasaki disease patients with CC compared with the healthy control group (p < 0.04; RR = 4.7). In a comparison between the subgroups, with and without CC, the frequency of the HLA-DRB1*09 allele was increased in the Kawasaki disease patients with CC compared with the Kawasaki disease patients without CC (33.3% vs 9.4%; p < 0.04). However, there was no significant difference in the frequency of these alleles when each was compared with the healthy control group. The frequency of the HLA-DRB1*04 allele was slightly increased in the Kawasaki disease patients without CC compared with the healthy control group (p < 0.05; RR = 1.9) (Table 5). Table 5The allele frequencies of human leukocyte antigen-DRB1 (HLA-DRB1) in the patients with Kawasaki disease and the control subjectsHLA allelesHealthy controls (n = 159) n (%)KD patients (n = 74) n (%)Coronary complicationsPresent (n = 21) n (%)Absent (n = 53) n (%)HLA-DRB10129 (18.2)8 (10.8)1 (4.8)7 (13.2)037 (4.4)1 (1.4)0 (0.0)1 (1.9)0448 (30.2)30 (40.5)6 (28.6)24 (45.3)a0726 (16.4)8 (10.8)1 (4.8)7 (13.2)0832 (20.1)14 (18.9)3 (14.3)11 (20.8)0928 (17.6)12 (16.2)7 (33.3)b5 (9.4)104 (2.5)4 (5.4)2 (9.5)2 (3.8)1110 (6.3)8 (10.8)5 (23.8)c3 (5.7)1218 (11.3)11 (14.9)2 (9.5)9 (17.0)1332 (20.1)10 (13.5)3 (14.3)7 (13.2)1421 (13.2)10 (13.5)3 (14.3)7 (13.2)1535 (22.0)20 (27.0)5 (23.8)15(28.3)164 (2.5)2 (2.7)1 (4.8)1 (1.9)KD, Kawasaki disease; RR, relative riskap < 0.05; RR = 1.9 (95% confidence interval [CI], 0.96-3.82) vs healthy control subjectsbp < 0.04 between KD patients with and without coronary complicationcp < 0.04; RR = 4.7 (95% CI, 1.26-17.17) vs healthy control subjects
###end p 53
###begin p 54
###xml 26 31 <span type="species:ncbi:9606">human</span>
###xml 73 81 <span type="species:ncbi:9606">patients</span>
The allele frequencies of human leukocyte antigen-DRB1 (HLA-DRB1) in the patients with Kawasaki disease and the control subjects
###end p 54
###begin p 55
KD, Kawasaki disease; RR, relative risk
###end p 55
###begin p 56
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
ap < 0.05; RR = 1.9 (95% confidence interval [CI], 0.96-3.82) vs healthy control subjects
###end p 56
###begin p 57
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 21 29 <span type="species:ncbi:9606">patients</span>
bp < 0.04 between KD patients with and without coronary complication
###end p 57
###begin p 58
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
cp < 0.04; RR = 4.7 (95% CI, 1.26-17.17) vs healthy control subjects
###end p 58
###begin title 59
Discussion
###end title 59
###begin p 60
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">22</xref>
###xml 710 712 710 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 714 716 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 718 720 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 31 39 <span type="species:ncbi:9606">patients</span>
###xml 159 167 <span type="species:ncbi:9606">patients</span>
###xml 269 277 <span type="species:ncbi:9606">Patients</span>
###xml 384 392 <span type="species:ncbi:9606">patients</span>
###xml 474 482 <span type="species:ncbi:9606">patients</span>
###xml 528 536 <span type="species:ncbi:9606">patients</span>
The prevalence of CC among the patients with Kawasaki disease in this study was higher than previously reported (28.4% vs 5%) [22]. This is likely because the patients included had a previous diagnosis of Kawasaki disease and were attending our clinic for this reason. Patients with more severe Kawasaki disease, including those with CC, present for medical care more frequently than patients without CC, and this may explain the higher proportion of CC in our study. Three patients (4%) had a positive family history, and four patients (5.4%) had a history of Kawasaki disease recurrence. Prior studies reported the familial occurrence and recurrence rates for Kawasaki disease to be 1% and 3%, respectively [11, 24, 28].
###end p 60
###begin p 61
###xml 33 41 <span type="species:ncbi:9606">children</span>
###xml 57 65 <span type="species:ncbi:9606">patients</span>
Our data were confined to Korean children and focused on patients who had Kawasaki disease with CC. Therefore, further research on the effect of the family history and recurrence of Kawasaki disease in association with HLA polymorphisms is needed.
###end p 61
###begin p 62
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 56 61 <span type="species:ncbi:9606">human</span>
###xml 506 514 <span type="species:ncbi:9606">patients</span>
Studies have associated HLA alleles with many different human diseases, such as HLA-B27 with ankylosing spondylitis and Reiter syndrome, HLA-B35 with subacute thyroiditis, and HLA-DR8 with juvenile rheumatoid arthritis. Most of the early studies on the genetics of Kawasaki disease were conducted using serologic testing that measured HLA antigens. The association of the HLA-Bw22 allele with Kawasaki disease in Japanese studies was evaluated with the microcytotoxicity test used for tissue typing of 205 patients with Kawasaki disease and 500 control samples in the late 1970s [14]. On basis of these studies, a gene was thought to control susceptibility to Kawasaki disease and was linked to the Japanese-specific HLA antigen.
###end p 62
###begin p 63
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 311 312 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
Since the clinical application of genetic technology became available in the 1980s, polymorphisms at many HLA loci have been identified. In addition, there were changes in nomenclature, and the alleles were reclassified. For example, the previously labeled HLA-Bw22 allele was changed to the HLA B54 allele [1, 3].
###end p 63
###begin p 64
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 726 728 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 256 264 <span type="species:ncbi:9606">patients</span>
###xml 509 517 <span type="species:ncbi:9606">children</span>
###xml 658 666 <span type="species:ncbi:9606">children</span>
Our study on the polymorphisms of HLA genes was conducted using the PCR-ARMS method for the HLA class I genes and the PCR-SSP method for the HLA class II genes. There was a significant increase in the frequencies of HLA-B35, -B75, and -Cw09 alleles in the patients with Kawasaki disease compared with the healthy control group. As previously mentioned, this study showed that the HLA-B35 allele was related to susceptibility to Kawasaki disease and the HLA-B75 allele to Kawasaki disease without CC in Korean children. These results suggest that polymorphisms (in some of the B and C loci) in HLA class I genes are associated with Kawasaki disease in Korean children; consistent with prior reports on other ethnic groups [12, 14, 16, 19].
###end p 64
###begin p 65
Review of the medical literature on Kawasaki disease and HLA shows that there is a trend toward an association between the HLA-B loci and Kawasaki disease. However, to date, there is no confirmed relationship to a particular locus. It is likely that the HLA-B locus is not the only locus associated with Kawasaki disease. This can be the case because of its functional variation or the potential effects from other related genes around the HLA-B locus. The HLA-B locus and other associated genes might be useful genetic markers for Kawasaki disease.
###end p 65
###begin p 66
###xml 200 201 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 102 105 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 121 129 <span type="species:ncbi:9606">patients</span>
###xml 195 198 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 361 369 <span type="species:ncbi:9606">children</span>
The HLA-B35 gene is known to play a major role in a variety of infections. For example, in cases with HIV infection, the patients with an increased frequency of HLA-B35 show rapid progression of HIV [9]. Infection has been implicated in the etiology of Kawasaki disease. The finding in our study that the frequency of the HLA-B35 allele was increased in Korean children with Kawasaki disease suggests a role for infection in Kawasaki disease.
###end p 66
###begin p 67
###xml 300 301 300 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 396 397 396 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 681 682 681 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 75 83 <span type="species:ncbi:9606">patients</span>
###xml 143 151 <span type="species:ncbi:9606">patients</span>
###xml 282 290 <span type="species:ncbi:9606">patients</span>
###xml 375 383 <span type="species:ncbi:9606">patients</span>
###xml 590 598 <span type="species:ncbi:9606">patients</span>
###xml 642 650 <span type="species:ncbi:9606">patients</span>
###xml 945 953 <span type="species:ncbi:9606">patients</span>
The HLA-DRB1 alleles showed no increased frequency in the Kawasaki disease patients compared with the healthy control group. However, when the patients were compared by subgroups, with and without CC, the frequency of HLA-DRB1*11 was significantly increased in the Kawasaki disease patients with CC (p < 0.04; RR = 4.7), and HLA-DRB1*04 was increased in the Kawasaki disease patients without CC (p < 0.05; RR =1.9) compared with the healthy control group. Comparison of the subgroups with and without CC showed that the frequency of the HLA-DRB1*09 allele was increased in Kawasaki disease patients with CC compared with the Kawasaki disease patients who had no CC (33.3% vs 9.4%; p < 0.04), and that there was no significant difference in comparison with the healthy control group. For the HLA-DRB1*11 allele, the finding of a higher allele frequency compared with the healthy control group was amplified by the subgrouping of Kawasaki disease patients with and without CC. Future studies with a larger sample size are needed to confirm these findings.
###end p 67
###begin p 68
###xml 85 86 85 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 364 365 364 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 367 368 367 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
Several reports describe the presence of HLA-DRB1 and the progression of infections [7]. However, most of the reports on the association of HLA-DRB1 with Kawasaki disease concluded that despite a regional association, their data failed to support a consistent role for HLA class II alleles in Kawasaki disease. If there was any role, it was predicted to be minor [2, 8].
###end p 68
###begin p 69
Interpopulation discrepancies of the frequencies of HLA alleles make generalization of results difficult. Matched population profiles are needed for disease association studies because ethnic differences can provide altered disease associations.
###end p 69
###begin p 70
###xml 59 67 <span type="species:ncbi:9606">patients</span>
###xml 211 219 <span type="species:ncbi:9606">patients</span>
In this study, we compared HLA alleles of Kawasaki disease patients with known polymorphic loci of HLA genes in healthy Korean adults. The results we report on the polymorphisms of HLA genes in Kawasaki disease patients may be limited to the Korean population. However, this information may be helpful in future studies on HLA genetic polymorphisms in Kawasaki disease. Further studies with a larger sample size are needed for confirmation of our findings.
###end p 70
###begin title 71
Open Access
###end title 71
###begin p 72
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
###end p 72
###begin title 73
References
###end title 73
###begin article-title 74
Five HLA-B22 group alleles in Japanese
###end article-title 74
###begin article-title 75
Major histocompatibility complex class II alleles in Kawasaki syndrome: Lack of consistent correlation with disease or cardiac involvement
###end article-title 75
###begin article-title 76
Nomenclature for factors of the HLA system, 1996
###end article-title 76
###begin article-title 77
Relationship of climate, ethnicity and socioeconomic status to Kawasaki disease in San Diego County, 1994 through 1998
###end article-title 77
###begin article-title 78
Rapid DNA typing for HLA-C using sequence-specific primers (PCR-SSP): Identification of serological and nonserologically defined HLA-C alleles including several new alleles
###end article-title 78
###begin article-title 79
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human leukocyte antigens in southern Chinese with Kawasaki disease
###end article-title 79
###begin article-title 80
###xml 71 82 <span type="species:ncbi:11103">hepatitis C</span>
Association between HLA class II genotype and spontaneous clearance of hepatitis C viraemia
###end article-title 80
###begin article-title 81
The HLA class II region and susceptibility to Kawasaki disease
###end article-title 81
###begin article-title 82
Associations of MHC ancestral haplotypes with resistance/susceptibility to AIDS disease development
###end article-title 82
###begin article-title 83
Kawasaki disease in families
###end article-title 83
###begin article-title 84
Incidence rate of recurrent Kawasaki disease and related risk factors: From the results of nationwide surveys of Kawasaki disease in Japan
###end article-title 84
###begin article-title 85
Polymorphism of transmembrane region of MICA gene and Kawasaki disease
###end article-title 85
###begin article-title 86
Association of epidemic Kawasaki syndrome with the HLA-A2, B44, Cw5 antigen combination
###end article-title 86
###begin article-title 87
HLA antigens in Kawasaki disease
###end article-title 87
###begin article-title 88
###xml 124 132 <span type="species:ncbi:9606">children</span>
Acute febrile mucocutaneous lymph node syndrome with lymphoid involvement with specific desquamation of fingers and toes in children
###end article-title 88
###begin article-title 89
###xml 70 78 <span type="species:ncbi:9606">patients</span>
HLA Bw51 is increased in mucocutaneous lymph node syndrome in Israeli patients
###end article-title 89
###begin article-title 90
HLA-A locus alleles identified by sequence specific PCR
###end article-title 90
###begin article-title 91
HLA antigens in mucocutaneous lymph node syndrome in New England
###end article-title 91
###begin article-title 92
Epidemic and endemic HLA-B and DR associations in mucocutaneous lymph node syndrome
###end article-title 92
###begin article-title 93
HLA antigens in mucocutaneous lymph node syndrome
###end article-title 93
###begin article-title 94
Two-generation Kawasaki disease: Mother and daughter
###end article-title 94
###begin article-title 95
Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
###end article-title 95
###begin article-title 96
HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation
###end article-title 96
###begin article-title 97
Epidemiologic picture of Kawasaki disease in Korea, 2000-2002
###end article-title 97
###begin article-title 98
Low-resolution DNA typing for HLA-B using sequence-specific primers in allele- or group-specific ARMS/PCR
###end article-title 98
###begin article-title 99
###xml 91 98 <span type="species:ncbi:9606">patient</span>
Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease
###end article-title 99
###begin article-title 100
Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan
###end article-title 100

